{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:14:47Z","timestamp":1783318487837,"version":"3.54.6"},"reference-count":227,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004429","name":"University of Crete","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004429","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antibiotics are among the transformative advances in medicine, but many interact with mammalian cellular targets and pathways beyond their antimicrobial activity. A clinically important expression of these off-target effects is hematologic toxicity, including immune-mediated cytopenias and direct bone marrow suppression. This narrative review examines whether the same biology that injures normal hematopoietic cells can, in selected contexts, reveal therapeutically exploitable vulnerabilities in leukemia. We synthesize molecular, clinical, and preclinical evidence and organize it into an integrative framework linking mitochondrial translation inhibition, mitonuclear imbalance, oxidative phosphorylation failure, reactive oxygen species generation, DNA\/topoisomerase stress, autophagy and lysosomal-flux blockade, and apoptosis modulation with both hematotoxicity and antileukemic activity. The strongest preclinical evidence supports selected tetracyclines, macrolides, and oxazolidinones, whereas evidence for beta-lactams, glycopeptides, polymyxins, rifamycins, fluoroquinolones, and folate-pathway agents remains more limited or largely hypothesis-generating. Importantly, antibiotic-induced cytopenia should not be interpreted as proof of leukemia selectivity: immune-mediated toxicity, supratherapeutic in vitro exposure, normal progenitor injury, pharmacokinetic constraints, microbiome effects, and resistance mechanisms all narrow the translational window. Overall, antibiotic hematotoxicity is best viewed as a biologically informative signal that can guide mechanism-based repurposing and combination strategies, but clinical development requires rigorous pharmacokinetic\/pharmacodynamic validation, normal hematopoietic comparators, and biomarker-driven patient selection.<\/jats:p>","DOI":"10.1007\/s00280-026-04916-7","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:33:28Z","timestamp":1783316008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Off-target anti-leukemic effects of antibiotics: mechanisms and therapeutic insights"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0052-706X","authenticated-orcid":false,"given":"Jason","family":"Charamis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0421-7712","authenticated-orcid":false,"given":"Nikolaos","family":"Katzilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-5110","authenticated-orcid":false,"given":"Eftichia","family":"Stiakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8153-9643","authenticated-orcid":false,"given":"Ioannis","family":"Kyriakidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"4916_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.ircmb.2023.03.009","volume":"377","author":"Gloria D\u2019Achille","year":"2023","unstructured":"D\u2019Achille G, Morroni G (2023) Side Effects of Antibiotics and Perturbations of Mitochondria Functions. In International Review of Cell and Molecular Biology; Elsevier, Vol. 377, pp. 121\u2013139 ISBN 978-0-443-19123-7. https:\/\/doi.org\/10.1016\/bs.ircmb.2023.03.009","journal-title":"Int Rev Cell Mol Biol"},{"key":"4916_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","volume":"51","author":"MI Hutchings","year":"2019","unstructured":"Hutchings MI, Truman AW, Wilkinson B, Antibiotics (2019) Past, Present and Future. Curr Opin Microbiol 51:72\u201380. https:\/\/doi.org\/10.1016\/j.mib.2019.10.008","journal-title":"Curr Opin Microbiol"},{"key":"4916_CR3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41594-023-01047-y","volume":"30","author":"H Paternoga","year":"2023","unstructured":"Paternoga H, Crowe-McAuliffe C, Bock LV, Koller TO, Morici M, Beckert B, Myasnikov AG, Grubm\u00fcller H, Nov\u00e1\u010dek J, Wilson DN (2023) Structural Conservation of Antibiotic Interaction with Ribosomes. Nat Struct Mol Biol 30:1380\u20131392. https:\/\/doi.org\/10.1038\/s41594-023-01047-y","journal-title":"Nat Struct Mol Biol"},{"key":"4916_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/17512433.2023.2181160","volume":"16","author":"D Cattaneo","year":"2023","unstructured":"Cattaneo D, Marriott DJ, Gervasoni C (2023) Hematological Toxicities Associated with Linezolid Therapy in Adults: Key Findings and Clinical Considerations. Expert Rev Clin Pharmacol 16:219\u2013230. https:\/\/doi.org\/10.1080\/17512433.2023.2181160","journal-title":"Expert Rev Clin Pharmacol"},{"key":"4916_CR5","doi-asserted-by":"publisher","unstructured":"Han H, Yan H, King KY (2021) Broad-Spectrum Antibiotics Deplete Bone Marrow Regulatory T Cells. Cells 10:277. https:\/\/doi.org\/10.3390\/cells10020277","DOI":"10.3390\/cells10020277"},{"key":"4916_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.21307\/immunohematology-2019-103","volume":"30","author":"BR Curtis","year":"2014","unstructured":"Curtis BR (2014) Drug-Induced Immune Neutropenia\/Agranulocytosis Immunohematology 30:95\u2013101 https:\/\/doi.org\/10.21307\/immunohematology-2019-103","journal-title":"Drug-Induced Immune Neutropenia\/Agranulocytosis Immunohematology"},{"key":"4916_CR7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/cancers17081355","volume":"17","author":"S Addanki","year":"2025","unstructured":"Addanki S, Kim L, Stevens A (2025) Understanding and Targeting Metabolic Vulnerabilities in Acute Myeloid Leukemia: An Updated Comprehensive Review. Cancers 17:1355. https:\/\/doi.org\/10.3390\/cancers17081355","journal-title":"Cancers"},{"key":"4916_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, Ashton JM, Pei S, Grose V, O\u2019Dwyer KM et al (2013) BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells. Cell Stem Cell 12:329\u2013341. https:\/\/doi.org\/10.1016\/j.stem.2012.12.013","journal-title":"Cell Stem Cell"},{"key":"4916_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, Bosc C, Sugita M, Stuani L, Fraisse M et al (2017) Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. Cancer Discov 7:716\u2013735. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0441","journal-title":"Cancer Discov"},{"issue":"e4","key":"4916_CR10","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Reisz JA, Culp-Hill R, Nemkov T, Pei S, Khan N, Adane B, Ye H et al (2018) Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells. Cancer Cell 34(e4):724\u2013740. https:\/\/doi.org\/10.1016\/j.ccell.2018.10.005","journal-title":"Cancer Cell"},{"key":"4916_CR11","doi-asserted-by":"publisher","first-page":"102814","DOI":"10.1016\/j.critrevonc.2019.102814","volume":"144","author":"K Mattes","year":"2019","unstructured":"Mattes K, Vellenga E, Schepers H (2019) Differential Redox-Regulation and Mitochondrial Dynamics in Normal and Leukemic Hematopoietic Stem Cells: A Potential Window for Leukemia Therapy. Crit Rev Oncol Hematol 144:102814. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.102814","journal-title":"Crit Rev Oncol Hematol"},{"key":"4916_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1182\/blood-2016-01-692244","volume":"128","author":"S Piya","year":"2016","unstructured":"Piya S, Kornblau SM, Ruvolo VR, Mu H, Ruvolo PP, McQueen T, Davis RE, Hail N, Kantarjian H, Andreeff M et al (2016) Atg7 Suppression Enhances Chemotherapeutic Agent Sensitivity and Overcomes Stroma-Mediated Chemoresistance in Acute Myeloid Leukemia. Blood 128:1260\u20131269. https:\/\/doi.org\/10.1182\/blood-2016-01-692244","journal-title":"Blood"},{"key":"4916_CR13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.300149","author":"S Miliara","year":"2026","unstructured":"Miliara S, Zhong X, Papadaki S, Devesa-Serrano D, \u00d6stlund Farrants A-K, Lehmann S, Bartek J, Kanellis DC, Lennartsson A (2026) Decoding the Actionable Potential of Ribosome Biogenesis in Acute Myeloid Leukemia. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2025.300149","journal-title":"Haematologica"},{"key":"4916_CR14","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.3390\/cancers13133193","volume":"13","author":"C Pfab","year":"2021","unstructured":"Pfab C, Schnobrich L, Eldnasoury S, Gessner A, El-Najjar N (2021) Repurposing of Antimicrobial Agents for Cancer Therapy. What Do We Know? Cancers 13:3193. https:\/\/doi.org\/10.3390\/cancers13133193","journal-title":"What Do We Know? Cancers"},{"key":"4916_CR15","doi-asserted-by":"publisher","first-page":"26762","DOI":"10.1021\/acsomega.4c00617","volume":"9","author":"N Bano","year":"2024","unstructured":"Bano N, Parveen S, Saeed M, Siddiqui S, Abohassan M, Mir SS (2024) Drug Repurposing of Selected Antibiotics: An Emerging Approach in Cancer Drug Discovery. ACS Omega 9:26762\u201326779. https:\/\/doi.org\/10.1021\/acsomega.4c00617","journal-title":"ACS Omega"},{"key":"4916_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-biochem-062917-011942","volume":"87","author":"J Lin","year":"2018","unstructured":"Lin J, Zhou D, Steitz TA, Polikanov YS, Gagnon MG, Ribosome-Targeting A (2018) Modes of Action, Mechanisms of Resistance, and Implications for Drug Design. Annu Rev Biochem 87:451\u2013478. https:\/\/doi.org\/10.1146\/annurev-biochem-062917-011942","journal-title":"Annu Rev Biochem"},{"key":"4916_CR17","doi-asserted-by":"publisher","first-page":"gkaf046","DOI":"10.1093\/nar\/gkaf046","volume":"53","author":"B Bibel","year":"2025","unstructured":"Bibel B, Raskar T, Couvillion M, Lee M, Kleinman JI, Takeuchi-Tomita N, Churchman LS, Fraser JS, Fujimori DG (2025) Context-Specific Inhibition of Mitochondrial Ribosomes by Phenicol and Oxazolidinone Antibiotics. Nucleic Acids Res 53:gkaf046. https:\/\/doi.org\/10.1093\/nar\/gkaf046","journal-title":"Nucleic Acids Res"},{"key":"4916_CR18","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.celrep.2015.02.034","volume":"10","author":"N Moullan","year":"2015","unstructured":"Moullan N, Mouchiroud L, Wang X, Ryu D, Williams EG, Mottis A, Jovaisaite V, Frochaux MV, Quiros PM, Deplancke B et al (2015) Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical Research. Cell Rep 10:1681\u20131691. https:\/\/doi.org\/10.1016\/j.celrep.2015.02.034","journal-title":"Cell Rep"},{"key":"4916_CR19","doi-asserted-by":"publisher","first-page":"975436","DOI":"10.3389\/fmicb.2022.975436","volume":"13","author":"T Franz","year":"2022","unstructured":"Franz T, Negele J, Bruno P, B\u00f6ttcher M, Mitchell-Flack M, Reemts L, Krone A, Mougiakakos D, M\u00fcller AJ, Zautner AE et al (2022) Pleiotropic Effects of Antibiotics on T Cell Metabolism and T Cell-Mediated Immunity. Front Microbiol 13:975436. https:\/\/doi.org\/10.3389\/fmicb.2022.975436","journal-title":"Front Microbiol"},{"key":"4916_CR20","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41467-024-49797-7","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Wang M, Denk T, Buschauer R, Li Y, Beckmann R, Cheng J (2024) Structural Basis for Differential Inhibition of Eukaryotic Ribosomes by Tigecycline. Nat Commun 15:5481. https:\/\/doi.org\/10.1038\/s41467-024-49797-7","journal-title":"Nat Commun"},{"key":"4916_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41589-019-0423-2","volume":"16","author":"J Choi","year":"2020","unstructured":"Choi J, Marks J, Zhang J, Chen D-H, Wang J, V\u00e1zquez-Laslop N, Mankin AS, Puglisi JD (2020) Dynamics of the Context-Specific Translation Arrest by Chloramphenicol and Linezolid. Nat Chem Biol 16:310\u2013317. https:\/\/doi.org\/10.1038\/s41589-019-0423-2","journal-title":"Nat Chem Biol"},{"key":"4916_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41594-022-00720-y","volume":"29","author":"EA Syroegin","year":"2022","unstructured":"Syroegin EA, Flemmich L, Klepacki D, Vazquez-Laslop N, Micura R, Polikanov YS (2022) Structural Basis for the Context-Specific Action of the Classic Peptidyl Transferase Inhibitor Chloramphenicol. Nat Struct Mol Biol 29:152\u2013161. https:\/\/doi.org\/10.1038\/s41594-022-00720-y","journal-title":"Nat Struct Mol Biol"},{"key":"4916_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/archinte.1970.00310080078010","volume":"126","author":"AA Yunis","year":"1970","unstructured":"Yunis AA, Smith US, Restrepo A (1970) Reversible Bone Marrow Suppression from Chloramphenicol. A Consequence of Mitochondrial Injury. Arch Intern Med 126:272\u2013275 https:\/\/doi.org\/10.1001\/archinte.1970.00310080078010","journal-title":"Arch Intern Med"},{"key":"4916_CR24","doi-asserted-by":"publisher","unstructured":"Leiter LM, Thatte HS, Okafor C, Marks PW, Golan DE, Bridges KR (1999) Chloramphenicol-Induced Mitochondrial Dysfunction Is Associated with Decreased Transferrin Receptor Expression and Ferritin Synthesis in K562 Cells and Is Unrelated to IRE-IRP Interactions. J Cell Physiol 180(199909):334\u2013344 https:\/\/doi.org\/10.1002\/(SICI)1097-4652(199909)180:3%3C334::AID-JCP4%3E3.0.CO;2-Q","DOI":"10.1002\/(SICI)1097-4652(199909)180:3%3C334::AID-JCP4%3E3.0.CO;2-Q"},{"key":"4916_CR25","doi-asserted-by":"publisher","unstructured":"Wilson DN, Schluenzen F, Harms JM, Starosta AL, Connell SR, Fucini P (2008) The Oxazolidinone Antibiotics Perturb the Ribosomal Peptidyl-Transferase Center and Effect tRNA Positioning. Proc. Natl. Acad. Sci. U.S.A. 105:13339\u201313344. https:\/\/doi.org\/10.1073\/pnas.0804276105","DOI":"10.1073\/pnas.0804276105"},{"key":"4916_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41594-022-00723-9","volume":"29","author":"K Tsai","year":"2022","unstructured":"Tsai K, Stojkovi\u0107 V, Lee DJ, Young ID, Szal T, Klepacki D, V\u00e1zquez-Laslop N, Mankin AS, Fraser JS, Fujimori DG (2022) Structural Basis for Context-Specific Inhibition of Translation by Oxazolidinone Antibiotics. Nat Struct Mol Biol 29:162\u2013171. https:\/\/doi.org\/10.1038\/s41594-022-00723-9","journal-title":"Nat Struct Mol Biol"},{"key":"4916_CR27","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1128\/AAC.01411-05","volume":"50","author":"EE McKee","year":"2006","unstructured":"McKee EE, Ferguson M, Bentley AT, Marks TA (2006) Inhibition of Mammalian Mitochondrial Protein Synthesis by Oxazolidinones. Antimicrob Agents Chemother 50:2042\u20132049. https:\/\/doi.org\/10.1128\/AAC.01411-05","journal-title":"Antimicrob Agents Chemother"},{"key":"4916_CR28","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1086\/501356","volume":"42","author":"AS De Vriese","year":"2006","unstructured":"De Vriese AS, Van Coster R, Smet J, Seneca S, Lovering A, Van Haute LL, Vanopdenbosch LJ, Martin J-J, Ceuterick-de Groote C, Vandecasteele S et al (2006) Linezolid-Induced Inhibition of Mitochondrial Protein Synthesis. Clin Infect Dis 42:1111\u20131117. https:\/\/doi.org\/10.1086\/501356","journal-title":"Clin Infect Dis"},{"key":"4916_CR29","doi-asserted-by":"publisher","first-page":"e01599","DOI":"10.1128\/AAC.01599-17","volume":"62","author":"TV Milosevic","year":"2018","unstructured":"Milosevic TV, Payen VL, Sonveaux P, Muccioli GG, Tulkens PM, Van Bambeke F (2018) Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 Monocytes. Antimicrob Agents Chemother 62:e01599\u2013e01517. https:\/\/doi.org\/10.1128\/AAC.01599-17","journal-title":"Antimicrob Agents Chemother"},{"key":"4916_CR30","doi-asserted-by":"publisher","first-page":"eadt5833","DOI":"10.1126\/sciadv.adt5833","volume":"11","author":"VTA Thu","year":"2025","unstructured":"Thu VTA, Nhu NQ, Anh NTV, Lim S-A, Seong H-J, Md Rasheduzzaman J, Kim U, Cho H-S, Soedarsono S, Shin J-G et al (2025) Deciphering Linezolid-Induced Hematologic Toxicity: Targeting TOP2A and TOP2B via Its Primary Metabolite PNU142586. Sci. Adv 11:eadt5833. https:\/\/doi.org\/10.1126\/sciadv.adt5833","journal-title":"Adv"},{"key":"4916_CR31","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1128\/AAC.49.9.3896-3902.2005","volume":"49","author":"EE Nagiec","year":"2005","unstructured":"Nagiec EE, Wu L, Swaney SM, Chosay JG, Ross DE, Brieland JK, Leach KL (2005) Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis. Antimicrob Agents Chemother 49:3896\u20133902. https:\/\/doi.org\/10.1128\/AAC.49.9.3896-3902.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"4916_CR32","doi-asserted-by":"publisher","first-page":"e22277","DOI":"10.1002\/jbt.22277","volume":"33","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Xiong T, Meng X, Yu D, Xiao Z, Song L (2019) Different Influences on Mitochondrial Function, Oxidative Stress and Cytotoxicity of Antibiotics on Primary Human Neuron and Cell Lines. J Biochem Mol Tox 33:e22277. https:\/\/doi.org\/10.1002\/jbt.22277","journal-title":"J Biochem Mol Tox"},{"key":"4916_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11010-019-03585-w","volume":"461","author":"P Prajapati","year":"2019","unstructured":"Prajapati P, Dalwadi P, Gohel D, Singh K, Sripada L, Bhatelia K, Joshi B, Roy M, Wang W-X, Springer JE et al (2019) Enforced Lysosomal Biogenesis Rescues Erythromycin- and Clindamycin-Induced Mitochondria-Mediated Cell Death in Human Cells. Mol Cell Biochem 461:23\u201336. https:\/\/doi.org\/10.1007\/s11010-019-03585-w","journal-title":"Mol Cell Biochem"},{"key":"4916_CR34","doi-asserted-by":"publisher","unstructured":"Kannan K, Kanabar P, Schryer D, Florin T, Oh E, Bahroos N, Tenson T, Weissman JS, Mankin AS (2014) The General Mode of Translation Inhibition by Macrolide Antibiotics. Proc. Natl. Acad. Sci. U.S.A. 111:15958\u201315963. https:\/\/doi.org\/10.1073\/pnas.1417334111","DOI":"10.1073\/pnas.1417334111"},{"key":"4916_CR35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","volume":"43","author":"N V\u00e1zquez-Laslop","year":"2018","unstructured":"V\u00e1zquez-Laslop N, Mankin AS (2018) How Macrolide Antibiotics Work. Trends Biochem Sci 43:668\u2013684. https:\/\/doi.org\/10.1016\/j.tibs.2018.06.011","journal-title":"Trends Biochem Sci"},{"key":"4916_CR36","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41467-021-23068-1","volume":"12","author":"MS Svetlov","year":"2021","unstructured":"Svetlov MS, Koller TO, Meydan S, Shankar V, Klepacki D, Polacek N, Guydosh NR, V\u00e1zquez-Laslop N, Wilson DN, Mankin AS (2021) Context-Specific Action of Macrolide Antibiotics on the Eukaryotic Ribosome. Nat Commun 12:2803. https:\/\/doi.org\/10.1038\/s41467-021-23068-1","journal-title":"Nat Commun"},{"key":"4916_CR37","doi-asserted-by":"publisher","unstructured":"De Vries H, Arendzen AJ, Kroon AM (1973) The Interference of the Macrolide Antibiotics with Mitochondrial Protein Synthesis. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 331:264\u2013275. https:\/\/doi.org\/10.1016\/0005-2787(73)90439-5","DOI":"10.1016\/0005-2787(73)90439-5"},{"key":"4916_CR38","doi-asserted-by":"publisher","unstructured":"Miller M, Singer M (2022) Do Antibiotics Cause Mitochondrial and Immune Cell Dysfunction? A Literature Review. J Antimicrob Chemother 77:1218\u20131227. https:\/\/doi.org\/10.1093\/jac\/dkac025","DOI":"10.1093\/jac\/dkac025"},{"key":"4916_CR39","doi-asserted-by":"publisher","unstructured":"Gupta A, \u00d6kesli-Armlovich A, Morgens D, Bassik MC, Khosla CA (2020) Genome-Wide Analysis of Targets of Macrolide Antibiotics in Mammalian Cells. J Biol Chem 295:2057\u20132067. https:\/\/doi.org\/10.1074\/jbc.RA119.010770","DOI":"10.1074\/jbc.RA119.010770"},{"key":"4916_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/00498254.2015.1046975","volume":"46","author":"A Salimi","year":"2016","unstructured":"Salimi A, Eybagi S, Seydi E, Naserzadeh P, Kazerouni NP, Pourahmad J (2016) Toxicity of Macrolide Antibiotics on Isolated Heart Mitochondria: A Justification for Their Cardiotoxic Adverse Effect. Xenobiotica 46:82\u201393. https:\/\/doi.org\/10.3109\/00498254.2015.1046975","journal-title":"Xenobiotica"},{"key":"4916_CR41","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3892\/ijo.2013.1870","volume":"42","author":"S Moriya","year":"2013","unstructured":"Moriya S, Che X-F, Komatsu S, Abe A, Kawaguchi T, Gotoh A, Inazu M, Tomoda A, Miyazawa K (2013) Macrolide Antibiotics Block Autophagy Flux and Sensitize to Bortezomib via Endoplasmic Reticulum Stress-Mediated CHOP Induction in Myeloma Cells. Int J Oncol 42:1541\u20131550. https:\/\/doi.org\/10.3892\/ijo.2013.1870","journal-title":"Int J Oncol"},{"key":"4916_CR42","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1038\/s41416-023-02210-4","volume":"128","author":"N Takano","year":"2023","unstructured":"Takano N, Hiramoto M, Yamada Y, Kokuba H, Tokuhisa M, Hino H, Miyazawa K (2023) Azithromycin, a Potent Autophagy Inhibitor for Cancer Therapy, Perturbs Cytoskeletal Protein Dynamics. Br J Cancer 128:1838\u20131849. https:\/\/doi.org\/10.1038\/s41416-023-02210-4","journal-title":"Br J Cancer"},{"key":"4916_CR43","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1182\/blood.V116.21.4786.4786","volume":"116","author":"F Zheng","year":"2010","unstructured":"Zheng F, Li H, Liu F, Du W, Huang S (2010) Role of hERG1 K+ Channels as a Positive Regulator In SDF-1alpha-Mediated Proliferation of Leukemia Cells and Leukemia Stem\/Progenitor Cells. Blood 116:4786\u20134786. https:\/\/doi.org\/10.1182\/blood.V116.21.4786.4786","journal-title":"Blood"},{"key":"4916_CR44","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/sj.leu.2402572","volume":"16","author":"S Pillozzi","year":"2002","unstructured":"Pillozzi S, Brizzi M, Balzi M, Crociani O, Cherubini A, Guasti L, Bartolozzi B, Becchetti A, Wanke E, Bernabei P et al (2002) HERG Potassium Channels Are Constitutively Expressed in Primary Human Acute Myeloid Leukemias and Regulate Cell Proliferation of Normal and Leukemic Hemopoietic Progenitors. Leukemia 16:1791\u20131798. https:\/\/doi.org\/10.1038\/sj.leu.2402572","journal-title":"Leukemia"},{"key":"4916_CR45","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1038\/bcj.2016.32","volume":"6","author":"S Pillozzi","year":"2016","unstructured":"Pillozzi S, Masselli M, Gasparoli L, D\u2019Amico M, Polletta L, Veltroni M, Favre C, Basso G, Becchetti A, Arcangeli A (2016) Macrolide Antibiotics Exert Antileukemic Effects by Modulating the Autophagic Flux through Inhibition of hERG1 Potassium Channels. Blood Cancer J 6:e423\u2013e423. https:\/\/doi.org\/10.1038\/bcj.2016.32","journal-title":"Blood Cancer J"},{"key":"4916_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF00944399","volume":"144","author":"M Nagai","year":"1995","unstructured":"Nagai M, Yamada H, Nakada S, Ochi K, Nemoto T, Takahara S, Hoshina S, Horiguchi-Yamada JA (1995) Macrolide Antibiotic, Roxithromycin, Inhibits the Growth of Human Myeloid Leukemia HL60 Cells by Producing Multinucleate Cells. Mol Cell Biochem 144:191\u2013195. https:\/\/doi.org\/10.1007\/BF00944399","journal-title":"Mol Cell Biochem"},{"key":"4916_CR47","doi-asserted-by":"publisher","unstructured":"Lima LM, Silva BNMD, Barbosa G, Barreiro EJ (2020) \u03b2-Lactam Antibiotics: An Overview from a Medicinal Chemistry Perspective. Eur J Med Chem 208:112829. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112829","DOI":"10.1016\/j.ejmech.2020.112829"},{"key":"4916_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cbi.2008.03.003","volume":"173","author":"L Pochini","year":"2008","unstructured":"Pochini L, Galluccio M, Scumaci D, Giangregorio N, Tonazzi A, Palmieri F, Indiveri C (2008) Interaction of \u03b2-Lactam Antibiotics with the Mitochondrial Carnitine\/Acylcarnitine Transporter. Chemico-Biol Interact 173:187\u2013194. https:\/\/doi.org\/10.1016\/j.cbi.2008.03.003","journal-title":"Chemico-Biol Interact"},{"key":"4916_CR49","doi-asserted-by":"publisher","unstructured":"Kalghatgi S, Spina CS, Costello JC, Liesa M, Morones-Ramirez JR, Slomovic S, Molina A, Shirihai OS, Collins JJ (2013) Bactericidal Antibiotics Induce Mitochondrial Dysfunction and Oxidative Damage in Mammalian Cells. Sci Transl Med 5. https:\/\/doi.org\/10.1126\/scitranslmed.3006055","DOI":"10.1126\/scitranslmed.3006055"},{"key":"4916_CR50","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1139\/cjpp-2016-0679","volume":"96","author":"S Jiang","year":"2018","unstructured":"Jiang S, Li T, Zhou X, Qin W, Wang Z, Liao Y (2018) Antibiotic Drug Piperacillin Induces Neuron Cell Death through Mitochondrial Dysfunction and Oxidative Damage. Can J Physiol Pharmacol 96:562\u2013568. https:\/\/doi.org\/10.1139\/cjpp-2016-0679","journal-title":"Can J Physiol Pharmacol"},{"key":"4916_CR51","doi-asserted-by":"publisher","first-page":"9497","DOI":"10.3390\/ijms21249497","volume":"21","author":"M Suzuki","year":"2020","unstructured":"Suzuki M, Asai Y, Kagi T, Noguchi T, Yamada M, Hirata Y, Matsuzawa A (2020) TAK1 Mediates ROS Generation Triggered by the Specific Cephalosporins through Noncanonical Mechanisms. IJMS 21:9497. https:\/\/doi.org\/10.3390\/ijms21249497","journal-title":"IJMS"},{"key":"4916_CR52","doi-asserted-by":"publisher","unstructured":"Li X, Li H, Li S, Zhu F, Kim DJ, Xie H, Li Y, Nadas J, Oi N, Zykova TA et al (2012) Ceftriaxone, an FDA-Approved Cephalosporin Antibiotic, Suppresses Lung Cancer Growth by Targeting Aurora B. Carcinogenesis 33:2548\u20132557. https:\/\/doi.org\/10.1093\/carcin\/bgs283","DOI":"10.1093\/carcin\/bgs283"},{"key":"4916_CR53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ja.2014.111","volume":"67","author":"MS Butler","year":"2014","unstructured":"Butler MS, Hansford KA, Blaskovich MAT, Halai R, Cooper MA (2014) Glycopeptide Antibiotics: Back to the Future. J Antibiot 67:631\u2013644. https:\/\/doi.org\/10.1038\/ja.2014.111","journal-title":"J Antibiot"},{"key":"4916_CR54","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","volume":"8","author":"RE Campbell","year":"2023","unstructured":"Campbell RE, Chen CH, Edelstein CL (2023) Overview of Antibiotic-Induced Nephrotoxicity. Kidney Int Rep 8:2211\u20132225. https:\/\/doi.org\/10.1016\/j.ekir.2023.08.031","journal-title":"Kidney Int Rep"},{"key":"4916_CR55","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.freeradbiomed.2012.02.038","volume":"52","author":"Y Arimura","year":"2012","unstructured":"Arimura Y, Yano T, Hirano M, Sakamoto Y, Egashira N, Oishi R (2012) Mitochondrial Superoxide Production Contributes to Vancomycin-Induced Renal Tubular Cell Apoptosis. Free Radic Biol Med 52:1865\u20131873. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.02.038","journal-title":"Free Radic Biol Med"},{"key":"4916_CR56","doi-asserted-by":"publisher","unstructured":"Henson KER, Levine MT, Wong EAH, Levine DP (2015) Glycopeptide Antibiotics: Evolving Resistance, Pharmacology and Adverse Event Profile. Expert Rev Anti-infective Therapy 13:1265\u20131278. https:\/\/doi.org\/10.1586\/14787210.2015.1068118","DOI":"10.1586\/14787210.2015.1068118"},{"key":"4916_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2017.02.025","volume":"800","author":"Y Sakamoto","year":"2017","unstructured":"Sakamoto Y, Yano T, Hanada Y, Takeshita A, Inagaki F, Masuda S, Matsunaga N, Koyanagi S, Ohdo S (2017) Vancomycin Induces Reactive Oxygen Species-Dependent Apoptosis via Mitochondrial Cardiolipin Peroxidation in Renal Tubular Epithelial Cells. Eur J Pharmacol 800:48\u201356. https:\/\/doi.org\/10.1016\/j.ejphar.2017.02.025","journal-title":"Eur J Pharmacol"},{"key":"4916_CR58","doi-asserted-by":"publisher","unstructured":"Paradies G, Paradies V, Ruggiero FM, Petrosillo G (2019) Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects. Cells 8:728. https:\/\/doi.org\/10.3390\/cells8070728","DOI":"10.3390\/cells8070728"},{"key":"4916_CR59","doi-asserted-by":"publisher","unstructured":"Jadhav AK, Karuppayil SM (2017) Molecular Docking Studies on Thirteen Fluoroquinolines with Human Topoisomerase II a and b. Silico Pharmacol 5(4). https:\/\/doi.org\/10.1007\/s40203-017-0024-2","DOI":"10.1007\/s40203-017-0024-2"},{"key":"4916_CR60","doi-asserted-by":"publisher","first-page":"9625","DOI":"10.1093\/nar\/gky793","volume":"46","author":"A Hangas","year":"2018","unstructured":"Hangas A, Aasumets K, Kek\u00e4l\u00e4inen NJ, Palohein\u00e4 M, Pohjoism\u00e4ki JL, Gerhold JM, Goffart S (2018) Ciprofloxacin Impairs Mitochondrial DNA Replication Initiation through Inhibition of Topoisomerase 2. Nucleic Acids Res 46:9625\u20139636. https:\/\/doi.org\/10.1093\/nar\/gky793","journal-title":"Nucleic Acids Res"},{"key":"4916_CR61","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1021\/acsomega.8b03428","volume":"4","author":"CA Fief","year":"2019","unstructured":"Fief CA, Hoang KG, Phipps SD, Wallace JL, Deweese JE (2019) Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase II\u03b1 and II\u03b2. ACS Omega 4:4049\u20134055. https:\/\/doi.org\/10.1021\/acsomega.8b03428","journal-title":"ACS Omega"},{"key":"4916_CR62","doi-asserted-by":"publisher","first-page":"e202421424","DOI":"10.1002\/anie.202421424","volume":"64","author":"T Reinhardt","year":"2025","unstructured":"Reinhardt T, El Harraoui Y, Rothemann A, Jauch AT, M\u00fcller-Deubert S, K\u00f6llen MF, Risch T, Jacobs LJ, M\u00fcller R, Traube FR et al (2025) Chemical Proteomics Reveals Human Off\u2010Targets of Fluoroquinolone Induced Mitochondrial Toxicity. Angew Chem Int Ed 64:e202421424. https:\/\/doi.org\/10.1002\/anie.202421424","journal-title":"Angew Chem Int Ed"},{"key":"4916_CR63","doi-asserted-by":"publisher","first-page":"e110784","DOI":"10.15252\/embj.2022110784","volume":"41","author":"SL Salscheider","year":"2022","unstructured":"Salscheider SL, Gerlich S, Cabrera-Orefice A, Peker E, Rothemann RA, Murschall LM, Finger Y, Szczepanowska K, Ahmadi ZA, Guerrero\u2010Castillo S et al (2022) AIFM1 Is a Component of the Mitochondrial Disulfide Relay That Drives Complex I Assembly through Efficient Import of NDUFS5. EMBO J 41:e110784. https:\/\/doi.org\/10.15252\/embj.2022110784","journal-title":"EMBO J"},{"key":"4916_CR64","doi-asserted-by":"publisher","unstructured":"Dai C, Tang S, Biao X, Xiao X, Chen C, Li J (2019) Colistin Induced Peripheral Neurotoxicity Involves Mitochondrial Dysfunction and Oxidative Stress in Mice. Mol Biol Rep, 46, 1963\u20131972, https:\/\/doi.org\/10.1007\/s11033-019-04646-5","DOI":"10.1007\/s11033-019-04646-5"},{"key":"4916_CR65","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1021\/cr030112j","volume":"105","author":"HG Floss","year":"2005","unstructured":"Floss HG, Yu T-W (2005) RifamycinMode of Action, Resistance, and Biosynthesis. Chem Rev 105:621\u2013632. https:\/\/doi.org\/10.1021\/cr030112j","journal-title":"Chem Rev"},{"key":"4916_CR66","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0014-5793(70)80414-8","volume":"10","author":"MN Gadaleta","year":"1970","unstructured":"Gadaleta MN, Greco M, Saccone C (1970) The Effect of Rifampicin on Mitochondrial RNA Polymerase from Rat Liver. FEBS Lett 10:54\u201356. https:\/\/doi.org\/10.1016\/0014-5793(70)80414-8","journal-title":"FEBS Lett"},{"key":"4916_CR67","doi-asserted-by":"publisher","unstructured":"Buss WC, Morgan R, Guttmann J, Barela T, Stalter K (1978) Rifampicin Inhibition of Protein Synthesis in Mammalian Cells. Sci 200:432\u2013434. https:\/\/doi.org\/10.1126\/science.644307","DOI":"10.1126\/science.644307"},{"key":"4916_CR68","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fcimb.2020.00493","volume":"10","author":"C Cahill","year":"2020","unstructured":"Cahill C, Phelan JJ, Keane J (2020) Understanding and Exploiting the Effect of Tuberculosis Antimicrobials on Host Mitochondrial Function and Bioenergetics. Front Cell Infect Microbiol 10:493. https:\/\/doi.org\/10.3389\/fcimb.2020.00493","journal-title":"Front Cell Infect Microbiol"},{"key":"4916_CR69","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41467-018-03447-x","volume":"9","author":"Y Minato","year":"2018","unstructured":"Minato Y, Dawadi S, Kordus SL, Sivanandam A, Aldrich CC, Baughn AD (2018) Mutual Potentiation Drives Synergy between Trimethoprim and Sulfamethoxazole. Nat Commun 9:1003. https:\/\/doi.org\/10.1038\/s41467-018-03447-x","journal-title":"Nat Commun"},{"key":"4916_CR70","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1126\/science.1232972","volume":"340","author":"H Haruki","year":"2013","unstructured":"Haruki H, Pedersen MG, Gorska KI, Pojer F, Johnsson K (2013) Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs. Science 340:987\u2013991. https:\/\/doi.org\/10.1126\/science.1232972","journal-title":"Science"},{"key":"4916_CR71","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1042\/BJ20110293","volume":"438","author":"ER Werner","year":"2011","unstructured":"Werner ER, Blau N, Th\u00f6ny B, Tetrahydrobiopterin (2011) Biochemistry and Pathophysiology. Biochem J 438:397\u2013414. https:\/\/doi.org\/10.1042\/BJ20110293","journal-title":"Biochem J"},{"key":"4916_CR72","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1096\/fasebj.13.13.1688","volume":"13","author":"DA Hess","year":"1999","unstructured":"Hess DA, Sisson ME, Suria H, Wijsman J, Puvanesasingham R, Madrenas J, Rieder MJ (1999) Cytotoxicity of Sulfonamide Reactive Metabolites: Apoptosis and Selective Toxicity of CD8\u2009+\u2009Cells by the Hydroxylamine of Sulfamethoxazole. FASEB J 13:1688\u20131698. https:\/\/doi.org\/10.1096\/fasebj.13.13.1688","journal-title":"FASEB J"},{"key":"4916_CR73","first-page":"9","volume":"15","author":"AE Cribb","year":"1996","unstructured":"Cribb AE, Lee BL, Trepanier LA, Spielberg SP (1996) Adverse Reactions to Sulphonamide and Sulphonamide-Trimethoprim Antimicrobials: Clinical Syndromes and Pathogenesis. Adverse Drug React Toxicol Rev 15:9\u201350","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"4916_CR74","doi-asserted-by":"publisher","first-page":"e00388","DOI":"10.1002\/prp2.388","volume":"6","author":"JM Reinhart","year":"2018","unstructured":"Reinhart JM, Rose W, Panyard DJ, Newton MA, Liebenstein TK, Yee J, Trepanier LA (2018) RNA Expression Profiling in Sulfamethoxazole-treated Patients with a Range of in Vitro Lymphocyte Cytotoxicity Phenotypes. Pharmacol Res Perspec 6:e00388. https:\/\/doi.org\/10.1002\/prp2.388","journal-title":"Pharmacol Res Perspec"},{"key":"4916_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/495863","volume":"2009","author":"DM Mintzer","year":"2009","unstructured":"Mintzer DM, Billet SN, Chmielewski L (2009) Drug-Induced Hematologic Syndromes. Adv Hematol 2009:1\u201311. https:\/\/doi.org\/10.1155\/2009\/495863","journal-title":"Adv Hematol"},{"key":"4916_CR76","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.pop.2016.07.010","volume":"43","author":"A Kovalszki","year":"2016","unstructured":"Kovalszki A, Weller PF, Eosinophilia (2016) Prim Care: Clin Office Pract 43:607\u2013617. https:\/\/doi.org\/10.1016\/j.pop.2016.07.010","journal-title":"Prim Care: Clin Office Pract"},{"key":"4916_CR77","doi-asserted-by":"crossref","unstructured":"Bonilla MA, Menell JS (2016) Disorders of White Blood Cells. In Lanzkowsky\u2019s Manual of Pediatric Hematology and Oncology; Elsevier, pp. 209\u2013238 ISBN 978-0-12-801368-7","DOI":"10.1016\/B978-0-12-801368-7.00013-2"},{"key":"4916_CR78","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMra066469","volume":"357","author":"RH Aster","year":"2007","unstructured":"Aster RH, Bougie DW (2007) Drug-Induced Immune Thrombocytopenia. N Engl J Med 357:580\u2013587. https:\/\/doi.org\/10.1056\/NEJMra066469","journal-title":"N Engl J Med"},{"key":"4916_CR79","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/S1098-3597(06)80053-0","volume":"8","author":"LS Schwartzberg","year":"2006","unstructured":"Schwartzberg LS, Neutropenia (2006) Etiology and Pathogenesis. Clin Cornerstone 8:S5\u2013S11. https:\/\/doi.org\/10.1016\/S1098-3597(06)80053-0","journal-title":"Clin Cornerstone"},{"key":"4916_CR80","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s44313-025-00079-1","volume":"60","author":"KI Min","year":"2025","unstructured":"Min KI, Byeon S (2025) Diagnosis and Management of Neutropenia. Blood Res 60:30. https:\/\/doi.org\/10.1007\/s44313-025-00079-1","journal-title":"Blood Res"},{"key":"4916_CR81","doi-asserted-by":"publisher","unstructured":"Andr\u00e8s E, Mourot-Cottet R, Maloisel F, S\u00e9verac F, Keller O, Vogel T, Tebacher M, Weber J-C, Kaltenbach G, Gottenberg J-E et al (2017) Idiosyncratic Drug-Induced Neutropenia Agranulocytosis QJM hcw220. https:\/\/doi.org\/10.1093\/qjmed\/hcw220","DOI":"10.1093\/qjmed\/hcw220"},{"key":"4916_CR82","doi-asserted-by":"publisher","unstructured":"Xiong C-Y, Yang Y-M, Zhou Y, He T-S, Luo X-W, Wang J, Mao C-X (2024) Systematic Analysis of the Adverse Effects of Commonly Used Clinical Tetracycline Drugs Based on the FAERS Database. Exp Opin Drug Saf 1\u20139. https:\/\/doi.org\/10.1080\/14740338.2024.2392865","DOI":"10.1080\/14740338.2024.2392865"},{"key":"4916_CR83","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1111\/bcp.15170","volume":"88","author":"JM Holz","year":"2022","unstructured":"Holz JM, Chevtchenko AV, Aitullina A (2022) Acute Antibiotically Induced Neutropenia: A Systematic Review of Case Reports. Brit J Clin Pharma 88:1978\u20131984. https:\/\/doi.org\/10.1111\/bcp.15170","journal-title":"Brit J Clin Pharma"},{"key":"4916_CR84","doi-asserted-by":"publisher","unstructured":"Peterson LR (2008) A Review of Tigecycline \u2014 the First Glycylcycline. Int J Antimicrob Agents 32:S215\u2013S222. https:\/\/doi.org\/10.1016\/S0924-8579(09)70005-6","DOI":"10.1016\/S0924-8579(09)70005-6"},{"key":"4916_CR85","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.2147\/IDR.S426259","volume":"16","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Zhao F, Jin P (2023) Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia. IDR 16:6225\u20136235. https:\/\/doi.org\/10.2147\/IDR.S426259","journal-title":"IDR"},{"key":"4916_CR86","doi-asserted-by":"publisher","unstructured":"Singh P, Sinha A, Kamath A, Malhotra S (2017) Very Severe Aplastic Anemia During Treatment With Doxycycline. Am J Ther 24:e492\u2013e492. https:\/\/doi.org\/10.1097\/MJT.0000000000000516","DOI":"10.1097\/MJT.0000000000000516"},{"key":"4916_CR87","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-07-6061","volume":"68","author":"Z-R Yuan","year":"2008","unstructured":"Yuan Z-R, Shi Y (2008) Chloramphenicol Induces Abnormal Differentiation and Inhibits Apoptosis in Activated T Cells. Cancer Res 68:4875\u20134881. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6061","journal-title":"Cancer Res"},{"key":"4916_CR88","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/jac\/dku530","volume":"70","author":"N Eliakim-Raz","year":"2015","unstructured":"Eliakim-Raz N, Lador A, Leibovici-Weissman Y, Elbaz M, Paul M, Leibovici L (2015) Efficacy and Safety of Chloramphenicol: Joining the Revival of Old Antibiotics? Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Antimicrob Chemother 70:979\u2013996. https:\/\/doi.org\/10.1093\/jac\/dku530","journal-title":"J Antimicrob Chemother"},{"key":"4916_CR89","first-page":"927","volume":"74","author":"OJ Martelo","year":"1969","unstructured":"Martelo OJ, Manyan DR, Smith US, Yunis AA (1969) Chloramphenicol and Bone Marrow Mitochondria. J Lab Clin Med 74:927\u2013940","journal-title":"J Lab Clin Med"},{"key":"4916_CR90","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/archinte.1970.00310080078010","volume":"126","author":"AA Yunis","year":"1970","unstructured":"Yunis AA (1970) Reversible Bone Marrow Suppression From Chloramphenicol: A Consequence of Mitochondrial Injury. Arch Intern Med 126:272. https:\/\/doi.org\/10.1001\/archinte.1970.00310080078010","journal-title":"Arch Intern Med"},{"key":"4916_CR91","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.pa.28.040188.000503","volume":"28","author":"AA Yunis","year":"1988","unstructured":"Yunis AA, Chloramphenicol (1988) Relation of Structure to Activity and Toxicity. Annu Rev Pharmacol Toxicol 28:83\u2013100. https:\/\/doi.org\/10.1146\/annurev.pa.28.040188.000503","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4916_CR92","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2613.2003.00232.x","volume":"83","author":"Ja Turton","year":"2002","unstructured":"Turton Ja, Andrews Cm, Havard Ac, Williams T (2002) c. Studies on the Haemotoxicity of Chloramphenicol Succinate in the Dunkin Hartley Guinea Pig. Int J Experimental Path 83:225\u2013238. https:\/\/doi.org\/10.1046\/j.1365-2613.2003.00232.x","journal-title":"Int J Experimental Path"},{"key":"4916_CR93","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/j.jaad.2013.07.017","volume":"69","author":"F Drago","year":"2013","unstructured":"Drago F, Agnoletti AF, Parodi A (2013) Acute Autoimmune Thrombocytopenia and Worsening of Dermatomyositis after Administration of Clarithromycin. J Am Acad Dermatol 69:e267\u2013e268. https:\/\/doi.org\/10.1016\/j.jaad.2013.07.017","journal-title":"J Am Acad Dermatol"},{"key":"4916_CR94","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000362437","volume":"59","author":"D Tsuji","year":"2013","unstructured":"Tsuji D, Kamezato M, Daimon T, Taku K, Hatori M, Ikeda M, Hayashi H, Inoue K, Eto T, Itoh K (2013) Retrospective Analysis of Severe Neutropenia in Patients Receiving Concomitant Administration of Docetaxel and Clarithromycin. Chemotherapy 59:407\u2013413. https:\/\/doi.org\/10.1159\/000362437","journal-title":"Chemotherapy"},{"key":"4916_CR95","doi-asserted-by":"publisher","first-page":"CD011825","DOI":"10.1002\/14651858.CD011825.pub2","volume":"1","author":"MP Hansen","year":"2019","unstructured":"Hansen MP, Scott AM, McCullough A, Thorning S, Aronson JK, Beller EM, Glasziou PP, Hoffmann TC, Clark J, Del Mar CB (2019) Adverse Events in People Taking Macrolide Antibiotics versus Placebo for Any Indication. Cochrane Database Syst Rev 1:CD011825. https:\/\/doi.org\/10.1002\/14651858.CD011825.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4916_CR96","doi-asserted-by":"publisher","first-page":"e932039","DOI":"10.12659\/AJCR.932039","volume":"22","author":"M Rossi","year":"2021","unstructured":"Rossi M, Capecchi M, Lazzerini PE (2021) Roxithromycin-Associated Acute Thrombocytopenia. Am J Case Rep 22:e932039. https:\/\/doi.org\/10.12659\/AJCR.932039","journal-title":"Am J Case Rep"},{"key":"4916_CR97","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijantimicag.2004.03.022","volume":"24","author":"Y Ishimatsu","year":"2004","unstructured":"Ishimatsu Y, Kadota J-I, Iwashita T, Nagata T, Ishii H, Shikuwa C, Kaida H, Mukae H, Kohno S (2004) Macrolide Antibiotics Induce Apoptosis of Human Peripheral Lymphocytes in Vitro. Int J Antimicrob Agents 24:247\u2013253. https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.03.022","journal-title":"Int J Antimicrob Agents"},{"key":"4916_CR98","doi-asserted-by":"publisher","unstructured":"Kadota J-I, Mizunoe S, Kishi K, Tokimatsu I, Nagai H, Nasu M (2005) Antibiotic-Induced Apoptosis in Human Activated Peripheral Lymphocytes. Int J Antimicrob Agents 25:216\u2013220. https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.10.009","DOI":"10.1016\/j.ijantimicag.2004.10.009"},{"key":"4916_CR99","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/FTD.0000000000000710","volume":"42","author":"GG Rao","year":"2020","unstructured":"Rao GG, Konicki R, Cattaneo D, Alffenaar J-W, Marriott DJE, Neely M (2020) On behalf of the IATDMCT Antimicrobial Scientific Committee Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics. Ther Drug Monit 42:83\u201392. https:\/\/doi.org\/10.1097\/FTD.0000000000000710","journal-title":"Ther Drug Monit"},{"key":"4916_CR100","doi-asserted-by":"publisher","first-page":"1338902","DOI":"10.3389\/fphar.2024.1338902","volume":"15","author":"F Zou","year":"2024","unstructured":"Zou F, Cui Z, Lou S, Ou Y, Zhu C, Shu C, Chen J, Zhao R, Wu Z, Wang L et al (2024) Adverse Drug Events Associated with Linezolid Administration: A Real-World Pharmacovigilance Study from 2004 to 2023 Using the FAERS Database. Front Pharmacol 15:1338902. https:\/\/doi.org\/10.3389\/fphar.2024.1338902","journal-title":"Front Pharmacol"},{"key":"4916_CR101","doi-asserted-by":"publisher","first-page":"e00533","DOI":"10.1128\/aac.00533-24","volume":"68","author":"TV Milosevic","year":"2024","unstructured":"Milosevic TV, Vertenoeil G, Vainchenker W, Tulkens PM, Constantinescu SN, Van Bambeke F (2024) Oxazolidinone Antibiotics Impair Ex Vivo Megakaryocyte Differentiation from Hematopoietic Progenitor Cells and Their Maturation into Platelets. Antimicrob Agents Chemother 68:e00533\u2013e00524. https:\/\/doi.org\/10.1128\/aac.00533-24","journal-title":"Antimicrob Agents Chemother"},{"key":"4916_CR102","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1586\/eri.10.26","volume":"8","author":"AR Renslo","year":"2010","unstructured":"Renslo AR (2010) Antibacterial Oxazolidinones: Emerging Structure\u2013Toxicity Relationships. Expert Rev Anti-infective Therapy 8:565\u2013574. https:\/\/doi.org\/10.1586\/eri.10.26","journal-title":"Expert Rev Anti-infective Therapy"},{"key":"4916_CR103","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1592\/phco.23.1.101.31920","volume":"23","author":"JS Bubalo","year":"2003","unstructured":"Bubalo JS, Blasdel CS, Bearden DT (2003) Neutropenia After Single-Dose Clindamycin for Dental Prophylaxis. Pharmacotherapy 23:101\u2013103. https:\/\/doi.org\/10.1592\/phco.23.1.101.31920","journal-title":"Pharmacotherapy"},{"key":"4916_CR104","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1177\/014556131209100420","volume":"91","author":"RS Schmidt","year":"2012","unstructured":"Schmidt RS, Reiter ER (2012) Clindamycin-Induced Neutropenia Following Major Head and Neck Surgery. Ear Nose Throat J 91:E27\u201329","journal-title":"Ear Nose Throat J"},{"key":"4916_CR105","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1752-1947-8-7","volume":"8","author":"MP Morales","year":"2014","unstructured":"Morales MP, Carvallo APT, Espinosa KAB, Murillo EEM (2014) A Young Man with Myelosuppression Caused by Clindamycin: A Case Report. J Med Case Rep 8:7. https:\/\/doi.org\/10.1186\/1752-1947-8-7","journal-title":"J Med Case Rep"},{"key":"4916_CR106","doi-asserted-by":"publisher","unstructured":"Neftel KA, Hauser SP, Muller MR (1985) Inhibition of Granulopoiesis in Vivo and in Vitro by \u03b2-Lactam Antibiotics. J Infect Dis 152:90\u201398. https:\/\/doi.org\/10.1093\/infdis\/152.1.90","DOI":"10.1093\/infdis\/152.1.90"},{"key":"4916_CR107","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.3390\/jcm9072212","volume":"9","author":"C Vayne","year":"2020","unstructured":"Vayne C, Gu\u00e9ry E-A, Rollin J, Baglo T, Petermann R, Gruel Y (2020) Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia. JCM 9:2212. https:\/\/doi.org\/10.3390\/jcm9072212","journal-title":"JCM"},{"key":"4916_CR108","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1177\/1060028020975646","volume":"55","author":"C Cimino","year":"2021","unstructured":"Cimino C, Allos BM, Phillips EJ (2021) A Review of \u03b2-Lactam\u2013Associated Neutropenia and Implications for Cross-Reactivity. Ann Pharmacother 55:1037\u20131049. https:\/\/doi.org\/10.1177\/1060028020975646","journal-title":"Ann Pharmacother"},{"key":"4916_CR109","doi-asserted-by":"publisher","first-page":"1505366","DOI":"10.3389\/fphar.2024.1505366","volume":"15","author":"L Zhang","year":"2025","unstructured":"Zhang L, Huang W, Xu J, Li Y, Zhu J (2025) Ceftriaxone-Induced Hemolytic Anemia Managed Successfully in a 54-Year-Old Woman: A Case Report and Literature Review. Front Pharmacol 15:1505366. https:\/\/doi.org\/10.3389\/fphar.2024.1505366","journal-title":"Front Pharmacol"},{"key":"4916_CR110","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/hematolrep17030030","volume":"17","author":"E Karisik","year":"2025","unstructured":"Karisik E, Stanojevic-Ristic Z, Jevtic M, Rasic J, Maric M, Popovic M (2025) Ceftriaxone-Induced Pancytopenia: A Case Report. Hematol Rep 17:30. https:\/\/doi.org\/10.3390\/hematolrep17030030","journal-title":"Hematol Rep"},{"key":"4916_CR111","doi-asserted-by":"publisher","unstructured":"Garratty G (2009) Drug-Induced Immune Hemolytic Anemia. Hematology 2009:73\u201379. https:\/\/doi.org\/10.1182\/asheducation-2009.1.73","DOI":"10.1182\/asheducation-2009.1.73"},{"key":"4916_CR112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2141.1985.tb02957.x","volume":"59","author":"MF Murphy","year":"1985","unstructured":"Murphy MF, Metcalfe P, Grint PCA, Green AR, Knowles S, Amess JAL, Waters AH (1985) Cephalosporin-induced Immune Neutropenia. Br J Haematol 59:9\u201314. https:\/\/doi.org\/10.1111\/j.1365-2141.1985.tb02957.x","journal-title":"Br J Haematol"},{"key":"4916_CR113","doi-asserted-by":"publisher","unstructured":"Olaison L, Belin L, Hogevik H, Alestig K (1999) Incidence of \u03b2-Lactam\u2013Induced Delayed Hypersensitivity and Neutropenia During Treatment of Infective Endocarditis. Arch Intern Med 159:607. https:\/\/doi.org\/10.1001\/archinte.159.6.607","DOI":"10.1001\/archinte.159.6.607"},{"key":"4916_CR114","doi-asserted-by":"publisher","first-page":"19","DOI":"10.12890\/2021_002215","volume":"8","author":"L Couto","year":"2021","unstructured":"Couto L, Goulart A, Valad\u00e3o I, Gar\u00e7a M, Santos MB, Cota P, Teixeira C (2021) Ceftriaxone-Induced Agranulocytosis. Eur J Case Rep Intern Med 8:19. https:\/\/doi.org\/10.12890\/2021_002215","journal-title":"Eur J Case Rep Intern Med"},{"key":"4916_CR115","doi-asserted-by":"publisher","first-page":"e243443","DOI":"10.1136\/bcr-2021-243443","volume":"14","author":"J Cachia","year":"2021","unstructured":"Cachia J, Torpiano P, Pace D, Meropenem-Induced Thrombocytopenia (2021) A Paediatric Case. BMJ Case Rep 14:e243443. https:\/\/doi.org\/10.1136\/bcr-2021-243443","journal-title":"BMJ Case Rep"},{"key":"4916_CR116","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13256-020-02632-1","volume":"15","author":"K Hussain","year":"2021","unstructured":"Hussain K, Salat MS, Mohammad N, Mughal A, Idrees S, Iqbal J, Ambreen G (2021) Meropenem-Induced Pancytopenia in a Preterm Neonate: A Case Report. J Med Case Rep 15:25. https:\/\/doi.org\/10.1186\/s13256-020-02632-1","journal-title":"J Med Case Rep"},{"key":"4916_CR117","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s43094-025-00858-8","volume":"11","author":"AE Altyar","year":"2025","unstructured":"Altyar AE, Kamran SH, Batool H, Saleem Z, Shahid N (2025) Investigating Thrombocytopenia in Meropenem-Treated Patients: A Cross-Sectional Observational Study. Futur J Pharm Sci 11:98. https:\/\/doi.org\/10.1186\/s43094-025-00858-8","journal-title":"Futur J Pharm Sci"},{"key":"4916_CR118","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5414\/CP204215","volume":"60","author":"W Qiao","year":"2022","unstructured":"Qiao W, Chang C, Wang Q, Cao X, Zhang X (2022) Imipenem Cilastatin Sodium-Associated Thrombocytopenia in an Older Patient: A Case Report and Literature Review. CP 60:358\u2013363. https:\/\/doi.org\/10.5414\/CP204215","journal-title":"CP"},{"key":"4916_CR119","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF01967266","volume":"12","author":"MC Farin\u00f1as","year":"1993","unstructured":"Farin\u00f1as MC, Vega T, Garmendia J, Gonz\u00e1lez-Mac\u00edas J (1993) Severe Neutropenia in a Patient Treated with Imipenem\/Cilastatin. Eur J Clin Microbiol Infect Dis 12:303\u2013304. https:\/\/doi.org\/10.1007\/BF01967266","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4916_CR120","doi-asserted-by":"publisher","first-page":"1524159","DOI":"10.3389\/fphar.2025.1524159","volume":"16","author":"P Jia","year":"2025","unstructured":"Jia P, Zhou Y, Gao Y, Wang S, Yin J, Lian Y, Lai Q (2025) Real-World Pharmacovigilance Investigation of Imipenem\/Cilastatin: Signal Detection Using the FDA Adverse Event Reporting System (FAERS) Database. Front Pharmacol 16:1524159. https:\/\/doi.org\/10.3389\/fphar.2025.1524159","journal-title":"Front Pharmacol"},{"key":"4916_CR121","doi-asserted-by":"publisher","first-page":"e1263","DOI":"10.7759\/cureus.1263","volume":"9","author":"RA Docobo","year":"2017","unstructured":"Docobo RA, Bukhari S, Qutrio Baloch Z (2017) Ertapenem-Induced Thrombocytosis. Cureus 9:e1263. https:\/\/doi.org\/10.7759\/cureus.1263","journal-title":"Cureus"},{"key":"4916_CR122","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12879-024-10393-1","volume":"25","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Huang L, Zhang J, Liang L, Jin P (2025) Incidence and Risk Factors of Vancomycin-Induced Thrombocytopenia: A Six-Year Real-World Study. BMC Infect Dis 25:7. https:\/\/doi.org\/10.1186\/s12879-024-10393-1","journal-title":"BMC Infect Dis"},{"key":"4916_CR123","doi-asserted-by":"publisher","unstructured":"Morris A, Ward C (1991) High Incidence of Vancomycin-Associated Leucopenia and Neutropenia in a Cardiothoracic Surgical Unit. J Infect 22:217\u2013223. https:\/\/doi.org\/10.1016\/S0163-4453(05)80002-7","DOI":"10.1016\/S0163-4453(05)80002-7"},{"key":"4916_CR124","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1345\/aph.1P583","volume":"45","author":"E Black","year":"2011","unstructured":"Black E, Lau TT, Ensom MH (2011) Vancomycin-Induced Neutropenia: Is It Dose- or Duration-Related? Ann Pharmacother 45:629\u2013638. https:\/\/doi.org\/10.1345\/aph.1P583","journal-title":"Ann Pharmacother"},{"key":"4916_CR125","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1177\/10600280221078123","volume":"56","author":"R Elajez","year":"2022","unstructured":"Elajez R, Abdallah I, Bakdach D, Shaat E, Osman E, Baraka M, Gergess R, Abdalla R, Al Hamoud E, Al Bakri M et al (2022) Thrombocytopenia Associated With Teicoplanin Use: A Retrospective Observational Study. Ann Pharmacother 56:1231\u20131236. https:\/\/doi.org\/10.1177\/10600280221078123","journal-title":"Ann Pharmacother"},{"key":"4916_CR126","doi-asserted-by":"publisher","first-page":"e5199","DOI":"10.7759\/cureus.5199","volume":"11","author":"A Kaur","year":"2019","unstructured":"Kaur A, Khan G, Grover P, Moormeier J (2019) Probable Vancomycin Induced Neutropenia: A Case Report. Cureus 11:e5199. https:\/\/doi.org\/10.7759\/cureus.5199","journal-title":"Cureus"},{"key":"4916_CR127","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/clinids\/23.4.844","volume":"23","author":"KK Lai","year":"1996","unstructured":"Lai KK, Kleinjan J, Belliveau P (1996) Vancomycin-Induced Neutropenia Treated with Granulocyte Colony-Stimulating Factor During Home Intravenous Infusion Therapy. Clin Infect Dis 23:844\u2013845. https:\/\/doi.org\/10.1093\/clinids\/23.4.844","journal-title":"Clin Infect Dis"},{"key":"4916_CR128","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1345\/aph.1E187","volume":"38","author":"M Segarra-Newnham","year":"2004","unstructured":"Segarra-Newnham M, Tagoff SS (2004) Probable Vancomycin-Induced Neutropenia. Ann Pharmacother 38:1855\u20131859. https:\/\/doi.org\/10.1345\/aph.1E187","journal-title":"Ann Pharmacother"},{"key":"4916_CR129","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1445-5994.2009.01996.x","volume":"39","author":"CY Cheah","year":"2009","unstructured":"Cheah CY, De Keulenaer B, Leahy MF (2009) Fluoroquinolone-induced Immune Thrombocytopenia: A Report and Review. Intern Med J 39:619\u2013623. https:\/\/doi.org\/10.1111\/j.1445-5994.2009.01996.x","journal-title":"Intern Med J"},{"key":"4916_CR130","doi-asserted-by":"publisher","first-page":"232470961770064","DOI":"10.1177\/2324709617700648","volume":"5","author":"W Chen","year":"2017","unstructured":"Chen W, Van Buren PN (2017) A Case of Severe Neutropenia From Short-Term Exposure to Moxifloxacin. J Investig Med High Impact Case Rep 5:2324709617700648. https:\/\/doi.org\/10.1177\/2324709617700648","journal-title":"J Investig Med High Impact Case Rep"},{"key":"4916_CR131","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10507","author":"J Moore","year":"2020","unstructured":"Moore J, Baer M, Grover BE, Aster RH, Millstein LS (2020) Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report. Cureus. https:\/\/doi.org\/10.7759\/cureus.10507","journal-title":"Cureus"},{"key":"4916_CR132","doi-asserted-by":"publisher","unstructured":"Landi AJ, Burkes R (2016) Probable Levofloxacin-Induced Thrombocytopenia in a Patient Previously on Ciprofloxacin: A Case Report and Literature Review. Case Rep Med 2016:1\u20133. https:\/\/doi.org\/10.1155\/2016\/2860645","DOI":"10.1155\/2016\/2860645"},{"key":"4916_CR133","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3109\/09537104.2015.1004044","volume":"26","author":"S Kupeli","year":"2015","unstructured":"Kupeli S, Colistin-Related Thrombocytopenia (2015) Platelets 26:812\u2013813. https:\/\/doi.org\/10.3109\/09537104.2015.1004044","journal-title":"Platelets"},{"key":"4916_CR134","doi-asserted-by":"publisher","first-page":"1537972","DOI":"10.3389\/fimmu.2025.1537972","volume":"16","author":"S Wan","year":"2025","unstructured":"Wan S, Zhu J-Q, Wang L (2025) Case Report: Polymyxin E-Associated Reversible Leukopenia. Front Immunol 16:1537972. https:\/\/doi.org\/10.3389\/fimmu.2025.1537972","journal-title":"Front Immunol"},{"key":"4916_CR135","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/microorganisms9071477","volume":"9","author":"ML Minardi","year":"2021","unstructured":"Minardi ML, Fato I, Di Gennaro F, Mosti S, Mastrobattista A, Cerva C, Libertone R, Saracino A, Goletti D, Girardi E et al (2021) Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art. Microorganisms 9:1477. https:\/\/doi.org\/10.3390\/microorganisms9071477","journal-title":"Microorganisms"},{"key":"4916_CR136","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/archpedi.1981.02130360008004","volume":"135","author":"BI Asmar","year":"1981","unstructured":"Asmar BI (1981) Hematologic Abnormalities After Oral Trimethoprim-Sulfamethoxazole Therapy in Children. Arch Pediatr Adolesc Med 135:1100. https:\/\/doi.org\/10.1001\/archpedi.1981.02130360008004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"4916_CR137","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/clinids\/4.2.426","volume":"4","author":"H Jick","year":"1982","unstructured":"Jick H (1982) Adverse Reactions to Trimethoprim-Sulfamethoxazole in Hospitalized Patients. Clin Infect Dis 4:426\u2013428. https:\/\/doi.org\/10.1093\/clinids\/4.2.426","journal-title":"Clin Infect Dis"},{"key":"4916_CR138","doi-asserted-by":"publisher","unstructured":"Hagen MD, White RD (1983) Thrombocytopenia Secondary to Trimethoprim-Sulfamethoxazole. South Med J 76:503. https:\/\/doi.org\/10.1097\/00007611-198304000-00025","DOI":"10.1097\/00007611-198304000-00025"},{"key":"4916_CR139","doi-asserted-by":"publisher","unstructured":"Keisu M, Wiholm B-E, Palmblad J (1990) Trimethoprim\u2010sulphamethoxazole\u2010associated Blood Dyscrasias. Ten Years\u2019experience of the Swedish Spontaneous Reporting System. J Intern Med 228:353\u2013360. https:\/\/doi.org\/10.1111\/j.1365-2796.1990.tb00245.x","DOI":"10.1111\/j.1365-2796.1990.tb00245.x"},{"key":"4916_CR140","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/00007611-199409000-00019","volume":"87","author":"A Herrington","year":"1994","unstructured":"Herrington A, Mahmood A, Berger R (1994) Treatment Options in Sulfamethoxazole-Trimethoprim-Induced Thrombocytopenic Purpura. South Med J 87:948\u2013950. https:\/\/doi.org\/10.1097\/00007611-199409000-00019","journal-title":"South Med J"},{"key":"4916_CR141","doi-asserted-by":"publisher","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","volume":"129","author":"JN George","year":"1998","unstructured":"George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T (1998) Drug-Induced Thrombocytopenia: A Systematic Review of Published Case Reports. Ann Intern Med 129:886\u2013890. https:\/\/doi.org\/10.7326\/0003-4819-129-11_Part_1-199812010-00009","journal-title":"Ann Intern Med"},{"key":"4916_CR142","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/j.jinf.2005.05.008","volume":"52","author":"Z Kocak","year":"2006","unstructured":"Kocak Z, Hatipoglu CA, Ertem G, Kinikli S, Tufan A, Irmak H, Demiroz AP (2006) Trimethoprim\u2013Sulfamethoxazole Induced Rash and Fatal Hematologic Disorders. J Infect 52:e49\u2013e52. https:\/\/doi.org\/10.1016\/j.jinf.2005.05.008","journal-title":"J Infect"},{"key":"4916_CR143","doi-asserted-by":"publisher","unstructured":"Gaudel P, Qavi AH, Basak P (2017) Life-Threatening Thrombocytopenia Secondary to Trimethoprim\/Sulfamethoxazole. Cureus 9:e1963 https:\/\/doi.org\/10.7759\/cureus.1963","DOI":"10.7759\/cureus.1963"},{"key":"4916_CR144","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1651-2227.1984.tb17772.x","volume":"73","author":"N Principi","year":"1984","unstructured":"Principi N, Marchisio P, Biasini A, Villa AD, Biasini G (1984) Early and Late Neutropenia in Children Treated with Cotrimoxazole (Trimethoprim-Sulfamethoxazole). Acta Paediatr 73:763\u2013767. https:\/\/doi.org\/10.1111\/j.1651-2227.1984.tb17772.x","journal-title":"Acta Paediatr"},{"key":"4916_CR145","first-page":"19","volume":"85","author":"GJ Harris","year":"1986","unstructured":"Harris GJ, Franson TR (1986) Neutropenia Induced by Short-Term Oral Trimethoprim-Sulfamethoxazole Therapy; Case Report. Wis Med J 85:19\u201321","journal-title":"Wis Med J"},{"key":"4916_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajh.2830230102","volume":"23","author":"BH Bjornson","year":"1986","unstructured":"Bjornson BH, McLntyre AP, Harvey JM, Tauber AI (1986) Studies of the Effects of Trimethoprim and Sulfamethoxazole on Human Granulopoiesis. Am J Hematol 23:1\u20137. https:\/\/doi.org\/10.1002\/ajh.2830230102","journal-title":"Am J Hematol"},{"key":"4916_CR147","first-page":"49","volume":"12","author":"A De Manzini","year":"1990","unstructured":"De Manzini A, Peratoner L, Lepore L (1990) [Neutropenia caused by low-dose trimethoprim-sulfamethoxazole in children with chronic pathology of the urinary tract]. Pediatr Med Chir 12:49\u201351","journal-title":"Pediatr Med Chir"},{"key":"4916_CR148","doi-asserted-by":"publisher","first-page":"e0285541","DOI":"10.1371\/journal.pone.0285541","volume":"18","author":"TB Jacobo-Vargas","year":"2023","unstructured":"Jacobo-Vargas TB, B\u00e1ez-Salda\u00f1a R, Cruz-Hervert LP, Fortoul TI, Ahumada-Topete VH, Rodr\u00edguez-Gan\u00e9n O, Vega-Barrientos RS (2023) Trimethoprim-Sulfamethoxazole-Associated Early Neutropenia in Mexican Adults Living with HIV: A Cohort Study. PLoS ONE 18:e0285541. https:\/\/doi.org\/10.1371\/journal.pone.0285541","journal-title":"PLoS ONE"},{"key":"4916_CR149","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/bmj.1.5643.578","volume":"1","author":"DI Evans","year":"1969","unstructured":"Evans DI, Tell R (1969) Agranulocytosis after Trimethoprim and Sulphamethoxazole. BMJ 1:578\u2013578. https:\/\/doi.org\/10.1136\/bmj.1.5643.578","journal-title":"BMJ"},{"key":"4916_CR150","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/bmj.4.5782.301-b","volume":"4","author":"IP Palva","year":"1971","unstructured":"Palva IP, Koivisto O (1971) Agranulocytosis Associated with Trimethoprim-Sulphamethoxazole. BMJ 4:301\u2013301. https:\/\/doi.org\/10.1136\/bmj.4.5782.301-b","journal-title":"BMJ"},{"key":"4916_CR151","doi-asserted-by":"crossref","unstructured":"Castanheira D, Marzella M, Skirvin JA (1998) Administration of Filgrastim in Two Patients with Drug-Induced Agranulocytosis. Pharmacotherapy 18:1347\u20131351","DOI":"10.1002\/j.1875-9114.1998.tb03158.x"},{"key":"4916_CR152","doi-asserted-by":"publisher","unstructured":"Jha A, Ghoz H, James N (2016) Severe Agranulocytosis Following Simultaneous Administration of Chlorpromazine and Trimethoprim-Sulfamethoxazole in a Patient with Sepsis: A Possible Toxic Combination. Case Rep Med 2016:1\u20133. https:\/\/doi.org\/10.1155\/2016\/5653497","DOI":"10.1155\/2016\/5653497"},{"key":"4916_CR153","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/08971900221128854","volume":"37","author":"D Bunch","year":"2024","unstructured":"Bunch D, Brands C, Langworthy DR (2024) Agranulocytosis Associated With Use of Sulfamethoxazole\/Trimethoprim in a Healthy Adult. J Pharm Pract 37:229\u2013233. https:\/\/doi.org\/10.1177\/08971900221128854","journal-title":"J Pharm Pract"},{"key":"4916_CR154","doi-asserted-by":"publisher","unstructured":"Parajuli P, Ibrahim AM, Siddiqui HH, Lara Garcia OE, Regmi MR (2019) Trimethoprim-Sulfamethoxazole Induced Pancytopenia: A Common Occurrence but A Rare Diagnosis. Cureus 11(e5071). https:\/\/doi.org\/10.7759\/cureus.5071","DOI":"10.7759\/cureus.5071"},{"key":"4916_CR155","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/clinpract11020050","volume":"11","author":"K Sawalha","year":"2021","unstructured":"Sawalha K, Sobash PT, Kamoga G-R (2021) A Rare Cause of Drug-Induced Pancytopenia: Trimethoprim\u2013Sulfamethoxazole-Induced Pancytopenia. Clin Pract 11:358\u2013362. https:\/\/doi.org\/10.3390\/clinpract11020050","journal-title":"Clin Pract"},{"key":"4916_CR156","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.75113","author":"J Chahal","year":"2024","unstructured":"Chahal J, Junko G (2024) Trimethoprim-Sulfamethoxazole-Induced Pancytopenia: A Case Report. Cureus. https:\/\/doi.org\/10.7759\/cureus.75113","journal-title":"Cureus"},{"key":"4916_CR157","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1038\/s41467-025-59388-9","volume":"16","author":"Q Shao","year":"2025","unstructured":"Shao Q, Khawaja A, Nguyen MD, Singh V, Zhang J, Liu Y, Nordin J, Adori M, Axel Innis C, Castro Dopico X et al (2025) T Cell Toxicity Induced by Tigecycline Binding to the Mitochondrial Ribosome. Nat Commun 16:4080. https:\/\/doi.org\/10.1038\/s41467-025-59388-9","journal-title":"Nat Commun"},{"key":"4916_CR158","doi-asserted-by":"publisher","first-page":"eabe9977","DOI":"10.1126\/science.abe9977","volume":"374","author":"M Lisci","year":"2021","unstructured":"Lisci M, Barton PR, Randzavola LO, Ma CY, Marchingo JM, Cantrell DA, Paupe V, Prudent J, Stinchcombe JC, Griffiths GM (2021) Mitochondrial Translation Is Required for Sustained Killing by Cytotoxic T Cells. Science 374:eabe9977. https:\/\/doi.org\/10.1126\/science.abe9977","journal-title":"Science"},{"key":"4916_CR159","doi-asserted-by":"publisher","first-page":"14331","DOI":"10.1073\/pnas.1916206117","volume":"117","author":"AJ Lamble","year":"2020","unstructured":"Lamble AJ, Kosaka Y, Laderas T, Maffit A, Kaempf A, Brady LK, Wang W, Long N, Saultz JN, Mori M et al (2020) Reversible Suppression of T Cell Function in the Bone Marrow Microenvironment of Acute Myeloid Leukemia. Proc Natl Acad Sci U S A 117:14331\u201314341. https:\/\/doi.org\/10.1073\/pnas.1916206117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4916_CR160","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","volume":"19","author":"C Li","year":"2020","unstructured":"Li C, Jiang P, Wei S, Xu X, Wang J (2020) Regulatory T Cells in Tumor Microenvironment: New Mechanisms, Potential Therapeutic Strategies and Future Prospects. Mol Cancer 19:116. https:\/\/doi.org\/10.1186\/s12943-020-01234-1","journal-title":"Mol Cancer"},{"key":"4916_CR161","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","volume":"20","author":"M \u0160krti\u0107","year":"2011","unstructured":"\u0160krti\u0107 M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z, Hurren R, Jitkova Y, Gronda M, Maclean N et al (2011) Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia. Cancer Cell 20:674\u2013688. https:\/\/doi.org\/10.1016\/j.ccr.2011.10.015","journal-title":"Cancer Cell"},{"key":"4916_CR162","first-page":"2395","volume":"7","author":"X Fu","year":"2017","unstructured":"Fu X, Liu W, Huang Q, Wang Y, Li H, Xiong Y (2017) Targeting Mitochondrial Respiration Selectively Sensitizes Pediatric Acute Lymphoblastic Leukemia Cell Lines and Patient Samples to Standard Chemotherapy. Am J Cancer Res 7:2395\u20132405","journal-title":"Am J Cancer Res"},{"key":"4916_CR163","doi-asserted-by":"publisher","first-page":"e58367","DOI":"10.1371\/journal.pone.0058367","volume":"8","author":"B Jhas","year":"2013","unstructured":"Jhas B, Sriskanthadevan S, Skrtic M, Sukhai MA, Voisin V, Jitkova Y, Gronda M, Hurren R, Laister RC, Bader GD et al (2013) Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells. PLoS ONE 8:e58367. https:\/\/doi.org\/10.1371\/journal.pone.0058367","journal-title":"PLoS ONE"},{"key":"4916_CR164","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13046-017-0512-6","volume":"36","author":"Z Lu","year":"2017","unstructured":"Lu Z, Xu N, He B, Pan C, Lan Y, Zhou H, Liu X (2017) Inhibition of Autophagy Enhances the Selective Anti-Cancer Activity of Tigecycline to Overcome Drug Resistance in the Treatment of Chronic Myeloid Leukemia. J Exp Clin Cancer Res 36:43. https:\/\/doi.org\/10.1186\/s13046-017-0512-6","journal-title":"J Exp Clin Cancer Res"},{"key":"4916_CR165","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1586\/ehm.12.8","volume":"5","author":"AD Schimmer","year":"2012","unstructured":"Schimmer AD, \u0160krti\u0107 M (2012) Therapeutic Potential of Mitochondrial Translation Inhibition for Treatment of Acute Myeloid Leukemia. Expert Rev Hematol 5:117\u2013119. https:\/\/doi.org\/10.1586\/ehm.12.8","journal-title":"Expert Rev Hematol"},{"key":"4916_CR166","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.3390\/ijms20143577","volume":"20","author":"Z Dong","year":"2019","unstructured":"Dong Z, Abbas MN, Kausar S, Yang J, Li L, Tan L, Cui H (2019) Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers. Int J Mol Sci 20:3577. https:\/\/doi.org\/10.3390\/ijms20143577","journal-title":"Int J Mol Sci"},{"key":"4916_CR167","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1182\/blood-2019-128171","volume":"134","author":"J Jin","year":"2019","unstructured":"Jin J, Tong H, Haiyang Y (2019) Combination of Tigecycline and Homoharringtonine Synergistically Enhances Anti-Leukemia and Anti-MDS Effect Followed By Inhibiting Mitochondrial Translation through AKT\/Mtorpathway and Downregulation of Anti-Apoptotic Proteins. Blood 134:5387\u20135387. https:\/\/doi.org\/10.1182\/blood-2019-128171","journal-title":"Blood"},{"key":"4916_CR168","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz EM, Baquero P, Michie AM, Dunn K, Tardito S, Holyoake TL, Helgason GV, Gottlieb E (2017) Targeting Mitochondrial Oxidative Phosphorylation Eradicates Therapy-Resistant Chronic Myeloid Leukemia Stem Cells. Nat Med 23:1234\u20131240. https:\/\/doi.org\/10.1038\/nm.4399","journal-title":"Nat Med"},{"key":"4916_CR169","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1002\/cam4.845","volume":"5","author":"GA Reed","year":"2016","unstructured":"Reed GA, Schiller GJ, Kambhampati S, Tallman MS, Douer D, Minden MD, Yee KW, Gupta V, Brandwein J, Jitkova Y et al (2016) A Phase 1 Study of Intravenous Infusions of Tigecycline in Patients with Acute Myeloid Leukemia. Cancer Med 5:3031\u20133040. https:\/\/doi.org\/10.1002\/cam4.845","journal-title":"Cancer Med"},{"key":"4916_CR170","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0145-2126(85)90142-0","volume":"9","author":"C Van Den Bogert","year":"1985","unstructured":"Van Den Bogert C, Dontje BHJ, Kroon AM (1985) The Antitumour Effect of Doxycycline on a T-Cell Leukaemia in the Rat. Leuk Res 9:617\u2013623. https:\/\/doi.org\/10.1016\/0145-2126(85)90142-0","journal-title":"Leuk Res"},{"key":"4916_CR171","first-page":"6686","volume":"48","author":"C Van den Bogert","year":"1988","unstructured":"Van den Bogert C, Dontje BH, Kroon AM (1988) Doxycycline in Combination Chemotherapy of a Rat Leukemia. Cancer Res 48:6686\u20136690","journal-title":"Cancer Res"},{"key":"4916_CR172","doi-asserted-by":"publisher","first-page":"e114457","DOI":"10.1371\/journal.pone.0114457","volume":"9","author":"H Song","year":"2014","unstructured":"Song H, Fares M, Maguire KR, Sid\u00e9n \u00c5, Pot\u00e1cov\u00e1 Z (2014) Cytotoxic Effects of Tetracycline Analogues (Doxycycline, Minocycline and COL-3) in Acute Myeloid Leukemia HL-60 Cells. PLoS ONE 9:e114457. https:\/\/doi.org\/10.1371\/journal.pone.0114457","journal-title":"PLoS ONE"},{"key":"4916_CR173","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1067\/mlc.2002.129308","volume":"140","author":"H Iwasaki","year":"2002","unstructured":"Iwasaki H, Inoue H, Mitsuke Y, Badran A, Ikegaya S, Ueda T (2002) Doxycycline Induces Apoptosis by Way of Caspase-3 Activation with Inhibition of Matrix Metalloproteinase in Human T-Lymphoblastic Leukemia CCRF-CEM Cells. J Lab Clin Med 140:382\u2013386. https:\/\/doi.org\/10.1067\/mlc.2002.129308","journal-title":"J Lab Clin Med"},{"key":"4916_CR174","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.3892\/mmr.2015.3833","volume":"12","author":"C Wang","year":"2015","unstructured":"Wang C, Xiang R, Zhang X, Chen Y (2015) Doxycycline Inhibits Leukemic Cell Migration via Inhibition of Matrix Metalloproteinases and Phosphorylation of Focal Adhesion Kinase. Mol Med Rep 12:3374\u20133380. https:\/\/doi.org\/10.3892\/mmr.2015.3833","journal-title":"Mol Med Rep"},{"key":"4916_CR175","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.tiv.2018.03.012","volume":"50","author":"C Ruiz-Moreno","year":"2018","unstructured":"Ruiz-Moreno C, Velez-Pardo C, Jimenez-Del-Rio M (2018) Minocycline Induces Apoptosis in Acute Lymphoblastic Leukemia Jurkat Cells. Toxicol In Vitro 50:336\u2013346. https:\/\/doi.org\/10.1016\/j.tiv.2018.03.012","journal-title":"Toxicol In Vitro"},{"key":"4916_CR176","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbrc.2015.05.043","volume":"463","author":"M Fares","year":"2015","unstructured":"Fares M, Abedi-Valugerdi M, Hassan M, Pot\u00e1cov\u00e1 ZDNA, Damage (2015) Lysosomal Degradation and Bcl-xL Deamidation in Doxycycline- and Minocycline-Induced Cell Death in the K562 Leukemic Cell Line. Biochem Biophys Res Commun 463:268\u2013274. https:\/\/doi.org\/10.1016\/j.bbrc.2015.05.043","journal-title":"Biochem Biophys Res Commun"},{"key":"4916_CR177","doi-asserted-by":"publisher","first-page":"51934","DOI":"10.18632\/oncotarget.10623","volume":"7","author":"F Tian","year":"2016","unstructured":"Tian F, Wang C, Tang M, Li J, Cheng X, Zhang S, Ji D, Huang Y, Li H (2016) The Antibiotic Chloramphenicol May Be an Effective New Agent for Inhibiting the Growth of Multiple Myeloma. Oncotarget 7:51934\u201351942. https:\/\/doi.org\/10.18632\/oncotarget.10623","journal-title":"Oncotarget"},{"key":"4916_CR178","doi-asserted-by":"publisher","first-page":"687","DOI":"10.5694\/j.1326-5377.1976.tb140975.x","volume":"1","author":"MA Schwarz","year":"1976","unstructured":"Schwarz MA, Firkin BG (1976) Chloramphenicol-a Possible Role in the Treatment of Leukaemia? Med J Aust 1:687\u2013690","journal-title":"Med J Aust"},{"key":"4916_CR179","first-page":"913","volume":"15","author":"Kang","year":"2005","unstructured":"Kang, Ki Young; Chul Hee Choi; Jae Young Oh (2005) Hyun Kim; Gi Ryang Kweon Chloramphenicol Arrests Transition of Cell Cycle and Induces Apoptotic Cell Death in Myelogenous Leukemia Cells. J Microbiol Biotechnol 15:913\u2013918","journal-title":"J Microbiol Biotechnol"},{"key":"4916_CR180","doi-asserted-by":"publisher","unstructured":"Van Nuffel AM (2015) Repurposing Drugs in Oncology (ReDO)\u2014Clarithromycin as an Anti-Cancer Agent. ecancer 9. https:\/\/doi.org\/10.3332\/ecancer.2015.513","DOI":"10.3332\/ecancer.2015.513"},{"key":"4916_CR181","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3109\/10428194.2012.698737","volume":"54","author":"L Schafranek","year":"2013","unstructured":"Schafranek L, Leclercq TM, White DL, Hughes TP (2013) Clarithromycin Enhances Dasatinib-Induced Cell Death in Chronic Myeloid Leukemia Cells, by Inhibition of Late Stage Autophagy. Leuk Lymphoma 54:198\u2013201. https:\/\/doi.org\/10.3109\/10428194.2012.698737","journal-title":"Leuk Lymphoma"},{"key":"4916_CR182","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1254\/jphs.08267FP","volume":"110","author":"M Fukui","year":"2009","unstructured":"Fukui M, Nagahara Y, Nishio Y, Honjoh T, Shinomiya T (2009) Rokitamycin Induces a Mitochondrial Defect and Caspase-Dependent Apoptosis in Human T-Cell Leukemia Jurkat Cells. J Pharmacol Sci 110:69\u201377. https:\/\/doi.org\/10.1254\/jphs.08267FP","journal-title":"J Pharmacol Sci"},{"key":"4916_CR183","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3109\/10428194.2012.656105","volume":"53","author":"AM Carella","year":"2012","unstructured":"Carella AM, Beltrami G, Pica G, Carella A, Catania G (2012) Clarithromycin Potentiates Tyrosine Kinase Inhibitor Treatment in Patients with Resistant Chronic Myeloid Leukemia. Leuk Lymphoma 53:1409\u20131411. https:\/\/doi.org\/10.3109\/10428194.2012.656105","journal-title":"Leuk Lymphoma"},{"key":"4916_CR184","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.18632\/oncotarget.3174","volume":"6","author":"R Lamb","year":"2015","unstructured":"Lamb R, Ozsvari B, Lisanti CL, Tanowitz HB, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP (2015) Antibiotics That Target Mitochondria Effectively Eradicate Cancer Stem Cells, across Multiple Tumor Types: Treating Cancer like an Infectious Disease. Oncotarget 6:4569\u20134584. https:\/\/doi.org\/10.18632\/oncotarget.3174","journal-title":"Oncotarget"},{"key":"4916_CR185","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1111\/cas.14992","volume":"112","author":"K Toriyama","year":"2021","unstructured":"Toriyama K, Takano N, Kokuba H, Kazama H, Moriya S, Hiramoto M, Abe S, Miyazawa K (2021) Azithromycin Enhances the Cytotoxicity of DNA-damaging Drugs via Lysosomal Membrane Permeabilization in Lung Cancer Cells. Cancer Sci 112:3324\u20133337. https:\/\/doi.org\/10.1111\/cas.14992","journal-title":"Cancer Sci"},{"key":"4916_CR186","doi-asserted-by":"publisher","first-page":"106523","DOI":"10.1016\/j.leukres.2021.106523","volume":"102","author":"T Ozkan","year":"2021","unstructured":"Ozkan T, Hekmatshoar Y, Karabay AZ, Koc A, Altinok Gunes B, Karadag Gurel A, Sunguroglu A (2021) Assessment of Azithromycin as an Anticancer Agent for Treatment of Imatinib Sensitive and Resistant CML Cells. Leuk Res 102:106523. https:\/\/doi.org\/10.1016\/j.leukres.2021.106523","journal-title":"Leuk Res"},{"key":"4916_CR187","doi-asserted-by":"publisher","first-page":"eaax2863","DOI":"10.1126\/scitranslmed.aax2863","volume":"11","author":"D Sharon","year":"2019","unstructured":"Sharon D, Cathelin S, Mirali S, Di Trani JM, Yanofsky DJ, Keon KA, Rubinstein JL, Schimmer AD, Ketela T, Chan SM (2019) Inhibition of Mitochondrial Translation Overcomes Venetoclax Resistance in AML through Activation of the Integrated Stress Response. Sci Transl Med 11:eaax2863. https:\/\/doi.org\/10.1126\/scitranslmed.aax2863","journal-title":"Sci Transl Med"},{"key":"4916_CR188","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0022-3565(25)23666-7","volume":"248","author":"E Somekh","year":"1989","unstructured":"Somekh E, Douer D, Shaked N, Rubinstein E (1989) Vitro Effects of Ciprofloxacin and Pefloxacin on Growth of Normal Human Hematopoietic Progenitor Cells and on Leukemic Cell Lines. J Pharmacol Exp Ther 248:415\u2013418","journal-title":"J Pharmacol Exp Ther"},{"key":"4916_CR189","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biopha.2018.12.119","volume":"111","author":"V Yadav","year":"2019","unstructured":"Yadav V, Talwar P (2019) Repositioning of Fluoroquinolones from Antibiotic to Anti-Cancer Agents: An Underestimated Truth. Biomed Pharmacother 111:934\u2013946. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.119","journal-title":"Biomed Pharmacother"},{"key":"4916_CR190","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s10895-023-03350-9","volume":"34","author":"N Pashapour","year":"2024","unstructured":"Pashapour N, Dehghan-Nayeri MJ, Babaei E, Khalaj-Kondori M, Mahdavi M (2024) The Assessment of Cytotoxicity, Apoptosis Inducing Activity and Molecular Docking of a New Ciprofloxacin Derivative in Human Leukemic Cells. J Fluoresc 34:1379\u20131389. https:\/\/doi.org\/10.1007\/s10895-023-03350-9","journal-title":"J Fluoresc"},{"key":"4916_CR191","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/ph18010072","volume":"18","author":"HM Hassan","year":"2025","unstructured":"Hassan HM, Hassan R, Elmagzoub RM, Al-Emam A, Kossenas K, Abdel-Samea AS, Khalifa HO, Akocak S, Br\u00e4se S, Hashem H (2025) From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents. Pharmaceuticals 18:72. https:\/\/doi.org\/10.3390\/ph18010072","journal-title":"Pharmaceuticals"},{"key":"4916_CR192","doi-asserted-by":"publisher","first-page":"28098","DOI":"10.1039\/d4ra03975k","volume":"14","author":"Z Mahmoud","year":"2024","unstructured":"Mahmoud Z, Ismail MM, Kamel M, Youssef A (2024) Levofloxacin Reposition-Based Design: Synthesis, Biological Evaluation of New Levofloxacin Derivatives Targeting Topoisomerase II Beta Polymerase as Promising Anticancer Agents, Molecular Docking, and Physicochemical Characterization. RSC Adv 14:28098\u201328119. https:\/\/doi.org\/10.1039\/d4ra03975k","journal-title":"RSC Adv"},{"key":"4916_CR193","doi-asserted-by":"publisher","first-page":"6407","DOI":"10.21873\/anticanres.12094","volume":"37","author":"S Nakai","year":"2017","unstructured":"Nakai S, Imaizumi T, Watanabe T, Iwase Y, Nishi K, Okudaira K, Yumita N (2017) Photodynamically-Induced Apoptosis Due to Ultraviolet A in the Presence of Lomefloxacin in Human Promyelocytic Leukemia Cells. Anticancer Res 37:6407\u20136413. https:\/\/doi.org\/10.21873\/anticanres.12094","journal-title":"Anticancer Res"},{"key":"4916_CR194","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1021\/jm7013259","volume":"51","author":"ME Katsarou","year":"2008","unstructured":"Katsarou ME, Efthimiadou EK, Psomas G, Karaliota A, Vourloumis D (2008) Novel Copper(II) Complex of N -Propyl-Norfloxacin and 1,10-Phenanthroline with Enhanced Antileukemic and DNA Nuclease Activities. J Med Chem 51:470\u2013478. https:\/\/doi.org\/10.1021\/jm7013259","journal-title":"J Med Chem"},{"key":"4916_CR195","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/sj.bjc.6603355","volume":"95","author":"I Fabian","year":"2006","unstructured":"Fabian I, Reuveni D, Levitov A, Halperin D, Priel E, Shalit I (2006) Moxifloxacin Enhances Antiproliferative and Apoptotic Effects of Etoposide but Inhibits Its Proinflammatory Effects in THP-1 and Jurkat Cells. Br J Cancer 95:1038\u20131046. https:\/\/doi.org\/10.1038\/sj.bjc.6603355","journal-title":"Br J Cancer"},{"key":"4916_CR196","doi-asserted-by":"publisher","unstructured":"Banerjee A, Dahiya M, Anand MT, Kumar S (2013) Inhibition of Proliferation of Cervical and Leukemic Cancer Cells by Penicillin G. Asian Pac J Cancer Prev 14:2127\u20132130. https:\/\/doi.org\/10.7314\/APJCP.2013.14.3.2127","DOI":"10.7314\/APJCP.2013.14.3.2127"},{"key":"4916_CR197","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1124\/mol.61.6.1348","volume":"61","author":"DM Smith","year":"2002","unstructured":"Smith DM, Kazi A, Smith L, Long TE, Heldreth B, Turos E, Dou QP (2002) A Novel \u03b2-Lactam Antibiotic Activates Tumor Cell Apoptotic Program by Inducing DNA Damage. Mol Pharmacol 61:1348\u20131358. https:\/\/doi.org\/10.1124\/mol.61.6.1348","journal-title":"Mol Pharmacol"},{"key":"4916_CR198","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.2741\/1420","volume":"9","author":"D Kuhn","year":"2004","unstructured":"Kuhn D (2004) Beta-Lactams and Their Potential Use as Novel Anticancer Chemotherapeutics Drugs. Front Biosci 9:2605. https:\/\/doi.org\/10.2741\/1420","journal-title":"Front Biosci"},{"key":"4916_CR199","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2741\/1611","volume":"10","author":"D Kuhn","year":"2005","unstructured":"Kuhn D, Structure-Activity Relationships J (2005) OF N-Methylthiolated Beta-Lactam Antibiotics with C3 Substitutions and Their Selective Induction of Apoptosis in Human Cancer Cells. Front Biosci 10:1183. https:\/\/doi.org\/10.2741\/1611","journal-title":"Front Biosci"},{"key":"4916_CR200","doi-asserted-by":"publisher","unstructured":"Verstov\u0161ek S, Maccubbin DL, Ehrke J, Mihich E (1993) Polymyxin B-Mediated Lysis of Tumor Cells. Int Arch Allergy Immunol 100:47\u201352 https:\/\/doi.org\/10.1159\/000236386","DOI":"10.1159\/000236386"},{"key":"4916_CR201","doi-asserted-by":"publisher","first-page":"e1601017","DOI":"10.1126\/sciadv.1601017","volume":"2","author":"V Speranzini","year":"2016","unstructured":"Speranzini V, Rotili D, Ciossani G, Pilotto S, Marrocco B, Forgione M, Lucidi A, Forneris F, Mehdipour P, Velankar S et al (2016) Polymyxins and Quinazolines Are LSD1\/KDM1A Inhibitors with Unusual Structural Features. Sci Adv 2:e1601017. https:\/\/doi.org\/10.1126\/sciadv.1601017","journal-title":"Sci Adv"},{"key":"4916_CR202","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nm.2661","volume":"18","author":"T Schenk","year":"2012","unstructured":"Schenk T, Chen WC, G\u00f6llner S, Howell L, Jin L, Hebestreit K, Klein H-U, Popescu AC, Burnett A, Mills K et al (2012) Inhibition of the LSD1 (KDM1A) Demethylase Reactivates the All-Trans-Retinoic Acid Differentiation Pathway in Acute Myeloid Leukemia. Nat Med 18:605\u2013611. https:\/\/doi.org\/10.1038\/nm.2661","journal-title":"Nat Med"},{"key":"4916_CR203","doi-asserted-by":"publisher","unstructured":"Rizzo S, Varache M, Sayers E, Jones A, Tonks A, Thomas D, Ferguson E (2024) Modification of the Antibiotic, Colistin, with Dextrin Causes Enhanced Cytotoxicity and Triggers Apoptosis in Myeloid Leukemia. IJN 19:5419\u20135437 https:\/\/doi.org\/10.2147\/IJN.S449185","DOI":"10.2147\/IJN.S449185"},{"key":"4916_CR204","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/0006-2952(95)00045-2","volume":"49","author":"O Fardel","year":"1995","unstructured":"Fardel O, Lecureur V, Loyer P, Guillouzo A (1995) Rifampicin Enhances Anti-Cancer Drug Accumulation and Activity in Multidrug-Resistant Cells. Biochem Pharmacol 49:1255\u20131260. https:\/\/doi.org\/10.1016\/0006-2952(95)00045-2","journal-title":"Biochem Pharmacol"},{"key":"4916_CR205","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1128\/AAC.01124-13","volume":"57","author":"B Williamson","year":"2013","unstructured":"Williamson B, Dooley KE, Zhang Y, Back DJ, Owen A (2013) Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine. Antimicrob Agents Chemother 57:6366\u20136369. https:\/\/doi.org\/10.1128\/AAC.01124-13","journal-title":"Antimicrob Agents Chemother"},{"key":"4916_CR206","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1515\/intox-2015-0004","volume":"8","author":"T Kashkolinejad-Koohi","year":"2015","unstructured":"Kashkolinejad-Koohi T, Saadat I, Saadat M (2015) Effects of Teicoplanin on Cell Number of Cultured Cell Lines. Interdisciplinary Toxicol 8:22\u201324. https:\/\/doi.org\/10.1515\/intox-2015-0004","journal-title":"Interdisciplinary Toxicol"},{"key":"4916_CR207","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2141.1981.tb02782.x","volume":"47","author":"GE Rivard","year":"1981","unstructured":"Rivard GE, Momparler LF, Momparler RL (1981) Effects of Trimethoprim on Leukaemic Cells in Vitro. Br J Haematol 47:221\u2013226. https:\/\/doi.org\/10.1111\/j.1365-2141.1981.tb02782.x","journal-title":"Br J Haematol"},{"key":"4916_CR208","doi-asserted-by":"publisher","unstructured":"Ferrazzini G, Klein J, Sulh H, Chung D, Griesbrecht E, Koren G (1990) Interaction between Trimethoprim-Sulfamethoxazole and Methotrexate in Children with Leukemia. J Pediatr 117:823\u2013826. https:\/\/doi.org\/10.1016\/S0022-3476(05)83351-7","DOI":"10.1016\/S0022-3476(05)83351-7"},{"key":"4916_CR209","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.addr.2020.09.012","volume":"158","author":"AS Khalil","year":"2020","unstructured":"Khalil AS, Jaenisch R, Mooney DJ (2020) Engineered Tissues and Strategies to Overcome Challenges in Drug Development. Adv Drug Deliv Rev 158:116\u2013139. https:\/\/doi.org\/10.1016\/j.addr.2020.09.012","journal-title":"Adv Drug Deliv Rev"},{"key":"4916_CR210","doi-asserted-by":"publisher","first-page":"e19510","DOI":"10.1200\/jco.2014.32.15_suppl.e19510","volume":"32","author":"AS Saad","year":"2014","unstructured":"Saad AS, Shaheen SM, Elhamamsy MH, Badary OA (2014) An Open-Label Randomized Controlled Phase II Study of Clarithromycin (CL) plus CVP in Patients (Pts) with Previously Untreated Stage III\/IV Indolent Non Hodgkin Lymphoma (NHL). J Clin Oncol 32:e19510\u2013e19510. https:\/\/doi.org\/10.1200\/jco.2014.32.15_suppl.e19510","journal-title":"J Clin Oncol"},{"key":"4916_CR211","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/annonc\/mdv214","volume":"26","author":"AJM Ferreri","year":"2015","unstructured":"Ferreri AJM, Sassone M, Kiesewetter B, Govi S, Scarf\u00f2 L, Donadoni G, Raderer M (2015) High-Dose Clarithromycin Is an Active Monotherapy for Patients with Relapsed\/Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT): The HD-K Phase II Trial. Ann Oncol 26:1760\u20131765. https:\/\/doi.org\/10.1093\/annonc\/mdv214","journal-title":"Ann Oncol"},{"key":"4916_CR212","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3324\/haematol.2022.281963","volume":"108","author":"MC Pirosa","year":"2023","unstructured":"Pirosa MC, Sassone M, Kiesewetter B, Guillermo AL, Devizzi L, Dom\u00e8nech ED, Tucci A, Mannina D, Merli M, Salar A et al (2023) IELSG40\/CLEO Phase II Trial of Clarithromycin and Lenalidomide in Relapsed\/Refractory Extranodal Marginal Zone Lymphoma. Haematologica 108:1671\u20131675. https:\/\/doi.org\/10.3324\/haematol.2022.281963","journal-title":"Haematologica"},{"key":"4916_CR213","doi-asserted-by":"publisher","first-page":"968729","DOI":"10.3389\/fimmu.2022.968729","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Huang G, Wong W-C, Hu D, Zhu J, Li R, Zhou H (2022) The Impact of Antibiotic Use on Clinical Features and Survival Outcomes of Cancer Patients Treated with Immune Checkpoint Inhibitors. Front Immunol 13:968729. https:\/\/doi.org\/10.3389\/fimmu.2022.968729","journal-title":"Front Immunol"},{"key":"4916_CR214","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/embo-reports\/kve062","volume":"2","author":"EC B\u00f6ttger","year":"2001","unstructured":"B\u00f6ttger EC, Springer B, Prammananan T, Kidan Y, Sander P (2001) Structural Basis for Selectivity and Toxicity of Ribosomal Antibiotics. EMBO Rep 2:318\u2013323. https:\/\/doi.org\/10.1093\/embo-reports\/kve062","journal-title":"EMBO Rep"},{"key":"4916_CR215","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bcp.2016.12.001","volume":"133","author":"J Sp\u00ed\u017eek","year":"2017","unstructured":"Sp\u00ed\u017eek J, \u0158ezanka T, Lincosamides (2017) Chemical Structure, Biosynthesis, Mechanism of Action, Resistance, and Applications. Biochem Pharmacol 133:20\u201328. https:\/\/doi.org\/10.1016\/j.bcp.2016.12.001","journal-title":"Biochem Pharmacol"},{"key":"4916_CR216","doi-asserted-by":"publisher","first-page":"19273","DOI":"10.1074\/jbc.M115.655092","volume":"290","author":"S Hong","year":"2015","unstructured":"Hong S, Harris KA, Fanning KD, Sarachan KL, Frohlich KM, Agris PF (2015) Evidence That Antibiotics Bind to Human Mitochondrial Ribosomal RNA Has Implications for Aminoglycoside Toxicity. J Biol Chem 290:19273\u201319286. https:\/\/doi.org\/10.1074\/jbc.M115.655092","journal-title":"J Biol Chem"},{"key":"4916_CR217","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ki.2010.11","volume":"77","author":"AI Morales","year":"2010","unstructured":"Morales AI, Detaille D, Prieto M, Puente A, Briones E, Ar\u00e9valo M, Leverve X, L\u00f3pez-Novoa JM, El-Mir M-Y (2010) Metformin Prevents Experimental Gentamicin-Induced Nephropathy by a Mitochondria-Dependent Pathway. Kidney Int 77:861\u2013869. https:\/\/doi.org\/10.1038\/ki.2010.11","journal-title":"Kidney Int"},{"key":"4916_CR218","doi-asserted-by":"publisher","unstructured":"O\u2019Reilly M, Young L, Kirkwood NK, Richardson GP, Kros CJ, Moore AL (2019) Gentamicin Affects the Bioenergetics of Isolated Mitochondria and Collapses the Mitochondrial Membrane Potential in Cochlear Sensory Hair Cells. Front Cell Neurosci 13. https:\/\/doi.org\/10.3389\/fncel.2019.00416","DOI":"10.3389\/fncel.2019.00416"},{"key":"4916_CR219","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1172\/jci84939","volume":"126","author":"R Esterberg","year":"2016","unstructured":"Esterberg R, Linbo T, Pickett SB, Wu P, Ou HC, Rubel EW, Raible DW (2016) Mitochondrial Calcium Uptake Underlies ROS Generation during Aminoglycoside-Induced Hair Cell Death. J Clin Invest 126:3556\u20133566. https:\/\/doi.org\/10.1172\/jci84939","journal-title":"J Clin Invest"},{"key":"4916_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1117\/1.jbo.24.5.051403","volume":"24","author":"DE Desa","year":"2018","unstructured":"Desa DE, Nichols MG, Smith HJ (2018) Aminoglycosides Rapidly Inhibit NAD(P)H Metabolism Increasing Reactive Oxygen Species and Cochlear Cell Demise. J Biomed Opt 24:1. https:\/\/doi.org\/10.1117\/1.jbo.24.5.051403","journal-title":"J Biomed Opt"},{"key":"4916_CR221","doi-asserted-by":"publisher","first-page":"e114650","DOI":"10.1371\/journal.pone.0114650","volume":"9","author":"J Yu","year":"2014","unstructured":"Yu J, Zheng J, Zhao X, Liu J, Mao Z, Ling Y, Chen D, Chen C, Hui L, Cui L et al (2014) Aminoglycoside Stress Together with the 12S rRNA 1494C\u2009>\u2009T Mutation Leads to Mitophagy. PLoS ONE 9:e114650. https:\/\/doi.org\/10.1371\/journal.pone.0114650","journal-title":"PLoS ONE"},{"key":"4916_CR222","doi-asserted-by":"publisher","unstructured":"Mosaei H, Zenkin N (2020) Inhibition of RNA Polymerase by Rifampicin and Rifamycin-Like Molecules. EcoSal Plus 9. https:\/\/doi.org\/10.1128\/ecosalplus.esp-0017-2019","DOI":"10.1128\/ecosalplus.esp-0017-2019"},{"key":"4916_CR223","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2174\/156802609789630947","volume":"9","author":"K Drlica","year":"2009","unstructured":"Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X (2009) Quinolones: Action and Resistance Updated. CTMC 9:981\u2013998. https:\/\/doi.org\/10.2174\/156802609789630947","journal-title":"CTMC"},{"key":"4916_CR224","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ja.2014.112","volume":"68","author":"YE Ha","year":"2015","unstructured":"Ha YE, Kong K-H, Cho M-H, Kim D-H, Song Y-S, Yoon S-Y (2015) Vancomycin Blocks Autophagy and Induces Interleukin-1\u03b2 Release in Macrophages. J Antibiot 68:76\u201380. https:\/\/doi.org\/10.1038\/ja.2014.112","journal-title":"J Antibiot"},{"key":"4916_CR225","doi-asserted-by":"publisher","first-page":"1424765","DOI":"10.3389\/fphar.2024.1424765","volume":"15","author":"S Yang","year":"2024","unstructured":"Yang S, Wang H, Zhao D, Zhang S, Hu C, Polymyxins (2024) Recent Advances and Challenges. Front Pharmacol 15:1424765. https:\/\/doi.org\/10.3389\/fphar.2024.1424765","journal-title":"Front Pharmacol"},{"key":"4916_CR226","doi-asserted-by":"publisher","first-page":"e00013","DOI":"10.1128\/AAC.00013-20","volume":"64","author":"AM Fathalla","year":"2020","unstructured":"Fathalla AM, Chow SH, Naderer T, Zhou QT, Velkov T, Azad MAK, Li J (2020) Polymyxin-Induced Cell Death of Human Macrophage-Like THP-1 and Neutrophil-Like HL-60 Cells Associated with the Activation of Apoptotic Pathways. Antimicrob Agents Chemother 64:e00013\u201320. https:\/\/doi.org\/10.1128\/AAC.00013-20","journal-title":"Antimicrob Agents Chemother"},{"key":"4916_CR227","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ja.2013.111","volume":"67","author":"ZZ Deris","year":"2014","unstructured":"Deris ZZ, Akter J, Sivanesan S, Roberts KD, Thompson PE, Nation RL, Li J, Velkov TA (2014) Secondary Mode of Action of Polymyxins against Gram-Negative Bacteria Involves the Inhibition of NADH-Quinone Oxidoreductase Activity. J Antibiot 67:147\u2013151. https:\/\/doi.org\/10.1038\/ja.2013.111","journal-title":"J Antibiot"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04916-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04916-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04916-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:33:34Z","timestamp":1783316014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04916-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":227,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4916"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04916-7","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"69"}}